# PeptideScanner evidence objects: Dulaglutide

Every published version of the records placed with Dulaglutide, one section per evidence object. The section anchor is the object's path id; the JSON twin is https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json. Selected public evidence only; not medical advice.

- Objects: 92
- Manifest: https://peptidescanner.com/evidence/v1/manifest.json

---

<a id="clinicaltrials-gov-nct01432938-dulaglutide-v1"></a>

## ClinicalTrials.gov record NCT01432938

> PeptideScanner retained ClinicalTrials.gov record NCT01432938 at 2026-07-30T21:54:46.558Z. Its registry update date was 2014-10-07, and PeptideScanner's reviewed identity mapping was dulaglutide.

- Evidence object: `story:clinicaltrials-gov-nct01432938-dulaglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2014-10-07
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01432938-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct01432938-dulaglutide-v1
- Content SHA-256: `9eea9fb643fb98c5def6f90ec93c23331a7483926c4b2b0fa235c6fede128c3b`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT01432938 ([`ctg-observation-nct01432938-2014-10-07-a2c6cb502717`](#source-ctg-observation-nct01432938-2014-10-07-a2c6cb502717))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01432938 at 2026-07-30T21:54:46.558Z. Its registry update date was 2014-10-07, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct01432938-2014-10-07-a2c6cb502717`](#source-ctg-observation-nct01432938-2014-10-07-a2c6cb502717))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01432938 at 2026-07-30T21:54:46.558Z. Its registry update date was 2014-10-07, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct01432938-2014-10-07-a2c6cb502717`](#source-ctg-observation-nct01432938-2014-10-07-a2c6cb502717))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01432938-2014-10-07-a2c6cb502717`](#source-ctg-observation-nct01432938-2014-10-07-a2c6cb502717))

### Sources

<a id="source-ctg-observation-nct01432938-2014-10-07-a2c6cb502717"></a>
- **ClinicalTrials.gov record NCT01432938 · retained source version 2014-10-07:a2c6cb50271756281f7a03bd4d3ace5220b49bd8265e5a9ef0b95d5bfdfa00e3** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01432938) (`ctg-observation-nct01432938-2014-10-07-a2c6cb502717`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01432938." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct01432938-dulaglutide-v1 SHA-256: 9eea9fb643fb98c5def6f90ec93c23331a7483926c4b2b0fa235c6fede128c3b.

---

<a id="clinicaltrials-gov-nct01436201-dulaglutide-v1"></a>

## ClinicalTrials.gov record NCT01436201

> PeptideScanner retained ClinicalTrials.gov record NCT01436201 at 2026-07-30T21:54:46.550Z. Its registry update date was 2014-10-07, and PeptideScanner's reviewed identity mapping was dulaglutide.

- Evidence object: `story:clinicaltrials-gov-nct01436201-dulaglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2014-10-07
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01436201-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct01436201-dulaglutide-v1
- Content SHA-256: `acd135b70c258f1dc49707ab137f4c11c65f67a3e52e0a61f223e8847c14bd08`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT01436201 ([`ctg-observation-nct01436201-2014-10-07-32e2ed4a098a`](#source-ctg-observation-nct01436201-2014-10-07-32e2ed4a098a))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01436201 at 2026-07-30T21:54:46.550Z. Its registry update date was 2014-10-07, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct01436201-2014-10-07-32e2ed4a098a`](#source-ctg-observation-nct01436201-2014-10-07-32e2ed4a098a))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01436201 at 2026-07-30T21:54:46.550Z. Its registry update date was 2014-10-07, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct01436201-2014-10-07-32e2ed4a098a`](#source-ctg-observation-nct01436201-2014-10-07-32e2ed4a098a))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01436201-2014-10-07-32e2ed4a098a`](#source-ctg-observation-nct01436201-2014-10-07-32e2ed4a098a))

### Sources

<a id="source-ctg-observation-nct01436201-2014-10-07-32e2ed4a098a"></a>
- **ClinicalTrials.gov record NCT01436201 · retained source version 2014-10-07:32e2ed4a098ada98601f0ca1238466e05a565ef7e8c2bdf0dc4c0a681d2950ee** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01436201) (`ctg-observation-nct01436201-2014-10-07-32e2ed4a098a`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01436201." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct01436201-dulaglutide-v1 SHA-256: acd135b70c258f1dc49707ab137f4c11c65f67a3e52e0a61f223e8847c14bd08.

---

<a id="clinicaltrials-gov-nct01524770-dulaglutide-v1"></a>

## ClinicalTrials.gov record NCT01524770

> PeptideScanner retained ClinicalTrials.gov record NCT01524770 at 2026-07-30T21:54:46.539Z. Its registry update date was 2014-10-22, and PeptideScanner's reviewed identity mapping was dulaglutide.

- Evidence object: `story:clinicaltrials-gov-nct01524770-dulaglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2014-10-22
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01524770-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct01524770-dulaglutide-v1
- Content SHA-256: `f0e98342a7a8278d53532b59a26117e1e421132b7710ef73d02a282551d4ef53`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT01524770 ([`ctg-observation-nct01524770-2014-10-22-f53b7389ba05`](#source-ctg-observation-nct01524770-2014-10-22-f53b7389ba05))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01524770 at 2026-07-30T21:54:46.539Z. Its registry update date was 2014-10-22, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct01524770-2014-10-22-f53b7389ba05`](#source-ctg-observation-nct01524770-2014-10-22-f53b7389ba05))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01524770 at 2026-07-30T21:54:46.539Z. Its registry update date was 2014-10-22, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct01524770-2014-10-22-f53b7389ba05`](#source-ctg-observation-nct01524770-2014-10-22-f53b7389ba05))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01524770-2014-10-22-f53b7389ba05`](#source-ctg-observation-nct01524770-2014-10-22-f53b7389ba05))

### Sources

<a id="source-ctg-observation-nct01524770-2014-10-22-f53b7389ba05"></a>
- **ClinicalTrials.gov record NCT01524770 · retained source version 2014-10-22:f53b7389ba059778770d18cea2d6b5da820eaa8e95e2a8a4c19cc88585321e57** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01524770) (`ctg-observation-nct01524770-2014-10-22-f53b7389ba05`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01524770." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct01524770-dulaglutide-v1 SHA-256: f0e98342a7a8278d53532b59a26117e1e421132b7710ef73d02a282551d4ef53.

---

<a id="clinicaltrials-gov-nct01667900-dulaglutide-v1"></a>

## ClinicalTrials.gov record NCT01667900

> PeptideScanner retained ClinicalTrials.gov record NCT01667900 at 2026-07-30T21:38:42.858Z. Its registry update date was 2016-03-07, and PeptideScanner's reviewed identity mapping was dulaglutide.

- Evidence object: `story:clinicaltrials-gov-nct01667900-dulaglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2016-03-07
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01667900-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct01667900-dulaglutide-v1
- Content SHA-256: `4bf19cc1fe6836f748a3747d80eb43db2b6ee17878775cc9f2cc7487e9cb1a57`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT01667900 ([`ctg-observation-nct01667900-2016-03-07-9a22543dbac4`](#source-ctg-observation-nct01667900-2016-03-07-9a22543dbac4))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01667900 at 2026-07-30T21:38:42.858Z. Its registry update date was 2016-03-07, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct01667900-2016-03-07-9a22543dbac4`](#source-ctg-observation-nct01667900-2016-03-07-9a22543dbac4))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01667900 at 2026-07-30T21:38:42.858Z. Its registry update date was 2016-03-07, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct01667900-2016-03-07-9a22543dbac4`](#source-ctg-observation-nct01667900-2016-03-07-9a22543dbac4))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01667900-2016-03-07-9a22543dbac4`](#source-ctg-observation-nct01667900-2016-03-07-9a22543dbac4))

### Sources

<a id="source-ctg-observation-nct01667900-2016-03-07-9a22543dbac4"></a>
- **ClinicalTrials.gov record NCT01667900 · retained source version 2016-03-07:9a22543dbac4de18fff3f7280d13b42b3fddb2bae3dd2803d2d7a11e69812de3** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01667900) (`ctg-observation-nct01667900-2016-03-07-9a22543dbac4`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01667900." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct01667900-dulaglutide-v1 SHA-256: 4bf19cc1fe6836f748a3747d80eb43db2b6ee17878775cc9f2cc7487e9cb1a57.

---

<a id="clinicaltrials-gov-nct03824002-dulaglutide-v1"></a>

## ClinicalTrials.gov record NCT03824002

> PeptideScanner retained ClinicalTrials.gov record NCT03824002 at 2026-07-30T20:57:18.709Z. Its registry update date was 2019-01-31, and PeptideScanner's reviewed identity mapping was dulaglutide.

- Evidence object: `story:clinicaltrials-gov-nct03824002-dulaglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2019-01-31
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03824002-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct03824002-dulaglutide-v1
- Content SHA-256: `0c83ae8dbe769f58167086a055665ff58aa637efb2d94f18529f1662317ad5dc`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT03824002 ([`ctg-observation-nct03824002-2019-01-31-166d2da9b45b`](#source-ctg-observation-nct03824002-2019-01-31-166d2da9b45b))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03824002 at 2026-07-30T20:57:18.709Z. Its registry update date was 2019-01-31, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct03824002-2019-01-31-166d2da9b45b`](#source-ctg-observation-nct03824002-2019-01-31-166d2da9b45b))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03824002 at 2026-07-30T20:57:18.709Z. Its registry update date was 2019-01-31, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct03824002-2019-01-31-166d2da9b45b`](#source-ctg-observation-nct03824002-2019-01-31-166d2da9b45b))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03824002-2019-01-31-166d2da9b45b`](#source-ctg-observation-nct03824002-2019-01-31-166d2da9b45b))

### Sources

<a id="source-ctg-observation-nct03824002-2019-01-31-166d2da9b45b"></a>
- **ClinicalTrials.gov record NCT03824002 · retained source version 2019-01-31:166d2da9b45bafbaa857bc0f09d4db7f1adf3c9968eff9193eef3d40cd307af9** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03824002) (`ctg-observation-nct03824002-2019-01-31-166d2da9b45b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03824002." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct03824002-dulaglutide-v1 SHA-256: 0c83ae8dbe769f58167086a055665ff58aa637efb2d94f18529f1662317ad5dc.

---

<a id="clinicaltrials-gov-nct05478707-dulaglutide-v1"></a>

## ClinicalTrials.gov record NCT05478707

> PeptideScanner retained ClinicalTrials.gov record NCT05478707 at 2026-08-13T05:54:14.860Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was dulaglutide.

- Evidence object: `story:clinicaltrials-gov-nct05478707-dulaglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-08-12
- Source checked: 2026-08-13
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05478707-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct05478707-dulaglutide-v1
- Content SHA-256: `dd4d17bb5c114e995522e2d4ee22bc4edf1ee85f8513d90272e033ace6120494`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT05478707 ([`ctg-observation-nct05478707-2026-08-12-d59fb7a72a7c`](#source-ctg-observation-nct05478707-2026-08-12-d59fb7a72a7c))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05478707 at 2026-08-13T05:54:14.860Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct05478707-2026-08-12-d59fb7a72a7c`](#source-ctg-observation-nct05478707-2026-08-12-d59fb7a72a7c))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05478707 at 2026-08-13T05:54:14.860Z. Its registry update date was 2026-08-12, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct05478707-2026-08-12-d59fb7a72a7c`](#source-ctg-observation-nct05478707-2026-08-12-d59fb7a72a7c))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05478707-2026-08-12-d59fb7a72a7c`](#source-ctg-observation-nct05478707-2026-08-12-d59fb7a72a7c))

### Sources

<a id="source-ctg-observation-nct05478707-2026-08-12-d59fb7a72a7c"></a>
- **ClinicalTrials.gov record NCT05478707 · retained source version 2026-08-12:d59fb7a72a7cb11dcfb34bfa1b0c4287bf0d0f7193a97a67cbc82f04cdfa44e7** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05478707) (`ctg-observation-nct05478707-2026-08-12-d59fb7a72a7c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05478707." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct05478707-dulaglutide-v1 SHA-256: dd4d17bb5c114e995522e2d4ee22bc4edf1ee85f8513d90272e033ace6120494.

---

<a id="clinicaltrials-gov-nct06739122-dulaglutide-v1"></a>

## ClinicalTrials.gov record NCT06739122

> PeptideScanner retained ClinicalTrials.gov record NCT06739122 at 2026-08-13T05:52:27.010Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was dulaglutide.

- Evidence object: `story:clinicaltrials-gov-nct06739122-dulaglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-08-07
- Source checked: 2026-08-13
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06739122-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct06739122-dulaglutide-v1
- Content SHA-256: `4b891b117f38089834f90af726874a43b088833322a1c05ea3c810c755000381`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06739122 ([`ctg-observation-nct06739122-2026-08-07-4e7b0d65d37a`](#source-ctg-observation-nct06739122-2026-08-07-4e7b0d65d37a))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06739122 at 2026-08-13T05:52:27.010Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct06739122-2026-08-07-4e7b0d65d37a`](#source-ctg-observation-nct06739122-2026-08-07-4e7b0d65d37a))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06739122 at 2026-08-13T05:52:27.010Z. Its registry update date was 2026-08-07, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct06739122-2026-08-07-4e7b0d65d37a`](#source-ctg-observation-nct06739122-2026-08-07-4e7b0d65d37a))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06739122-2026-08-07-4e7b0d65d37a`](#source-ctg-observation-nct06739122-2026-08-07-4e7b0d65d37a))

### Sources

<a id="source-ctg-observation-nct06739122-2026-08-07-4e7b0d65d37a"></a>
- **ClinicalTrials.gov record NCT06739122 · retained source version 2026-08-07:4e7b0d65d37a4fd3262d4fc0128ccd28bc4df252f65638ac794eb649a8dcbe35** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06739122) (`ctg-observation-nct06739122-2026-08-07-4e7b0d65d37a`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06739122." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct06739122-dulaglutide-v1 SHA-256: 4b891b117f38089834f90af726874a43b088833322a1c05ea3c810c755000381.

---

<a id="clinicaltrials-gov-nct06851962-dulaglutide-v1"></a>

## ClinicalTrials.gov record NCT06851962

> PeptideScanner retained ClinicalTrials.gov record NCT06851962 at 2026-09-09T19:17:17.407Z. Its registry update date was 2026-09-04, and PeptideScanner's reviewed identity mapping was dulaglutide.

- Evidence object: `story:clinicaltrials-gov-nct06851962-dulaglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-09-04
- Source checked: 2026-09-09
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06851962-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct06851962-dulaglutide-v1
- Content SHA-256: `abb59f6dad5b6a47018e970fb3e8965ac740db316f532257290053f3b122a147`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06851962 ([`ctg-observation-nct06851962-2026-09-04-0385163138fd`](#source-ctg-observation-nct06851962-2026-09-04-0385163138fd))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06851962 at 2026-09-09T19:17:17.407Z. Its registry update date was 2026-09-04, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct06851962-2026-09-04-0385163138fd`](#source-ctg-observation-nct06851962-2026-09-04-0385163138fd))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06851962 at 2026-09-09T19:17:17.407Z. Its registry update date was 2026-09-04, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct06851962-2026-09-04-0385163138fd`](#source-ctg-observation-nct06851962-2026-09-04-0385163138fd))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06851962-2026-09-04-0385163138fd`](#source-ctg-observation-nct06851962-2026-09-04-0385163138fd))

### Sources

<a id="source-ctg-observation-nct06851962-2026-09-04-0385163138fd"></a>
- **ClinicalTrials.gov record NCT06851962 · retained source version 2026-09-04:0385163138fd0b6137377c4b641f3184e88dae54c1363736b4830b61c27d2cb3** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06851962) (`ctg-observation-nct06851962-2026-09-04-0385163138fd`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06851962." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct06851962-dulaglutide-v1 SHA-256: abb59f6dad5b6a47018e970fb3e8965ac740db316f532257290053f3b122a147.

---

<a id="clinicaltrials-gov-nct07313813-dulaglutide-v1"></a>

## ClinicalTrials.gov record NCT07313813

> PeptideScanner retained ClinicalTrials.gov record NCT07313813 at 2026-09-09T19:17:17.407Z. Its registry update date was 2026-08-21, and PeptideScanner's reviewed identity mapping was dulaglutide.

- Evidence object: `story:clinicaltrials-gov-nct07313813-dulaglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-08-21
- Source checked: 2026-09-09
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07313813-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct07313813-dulaglutide-v1
- Content SHA-256: `09fc9a148efbf840557d8e21539056c499164a19c660bbb3dd684475a4abfdcc`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07313813 ([`ctg-observation-nct07313813-2026-08-21-132503bb031b`](#source-ctg-observation-nct07313813-2026-08-21-132503bb031b))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07313813 at 2026-09-09T19:17:17.407Z. Its registry update date was 2026-08-21, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct07313813-2026-08-21-132503bb031b`](#source-ctg-observation-nct07313813-2026-08-21-132503bb031b))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07313813 at 2026-09-09T19:17:17.407Z. Its registry update date was 2026-08-21, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct07313813-2026-08-21-132503bb031b`](#source-ctg-observation-nct07313813-2026-08-21-132503bb031b))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07313813-2026-08-21-132503bb031b`](#source-ctg-observation-nct07313813-2026-08-21-132503bb031b))

### Sources

<a id="source-ctg-observation-nct07313813-2026-08-21-132503bb031b"></a>
- **ClinicalTrials.gov record NCT07313813 · retained source version 2026-08-21:132503bb031b59f3ea909b928514160625d7c9b09f0a28df434713873b45df28** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07313813) (`ctg-observation-nct07313813-2026-08-21-132503bb031b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07313813." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct07313813-dulaglutide-v1 SHA-256: 09fc9a148efbf840557d8e21539056c499164a19c660bbb3dd684475a4abfdcc.

---

<a id="clinicaltrials-gov-nct07417631-dulaglutide-v1"></a>

## ClinicalTrials.gov record NCT07417631

> PeptideScanner retained ClinicalTrials.gov record NCT07417631 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-10, and PeptideScanner's reviewed identity mapping was dulaglutide.

- Evidence object: `story:clinicaltrials-gov-nct07417631-dulaglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-10
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07417631-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct07417631-dulaglutide-v1
- Content SHA-256: `d57d6efa47282c5f5e73f44ed4ab21beeae263c40b94d91f82e557568b0009a8`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07417631 ([`ctg-observation-nct07417631-2026-07-10-a407914bd3ae`](#source-ctg-observation-nct07417631-2026-07-10-a407914bd3ae))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07417631 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-10, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct07417631-2026-07-10-a407914bd3ae`](#source-ctg-observation-nct07417631-2026-07-10-a407914bd3ae))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07417631 at 2026-08-10T18:10:04.224Z. Its registry update date was 2026-07-10, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct07417631-2026-07-10-a407914bd3ae`](#source-ctg-observation-nct07417631-2026-07-10-a407914bd3ae))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07417631-2026-07-10-a407914bd3ae`](#source-ctg-observation-nct07417631-2026-07-10-a407914bd3ae))

### Sources

<a id="source-ctg-observation-nct07417631-2026-07-10-a407914bd3ae"></a>
- **ClinicalTrials.gov record NCT07417631 · retained source version 2026-07-10:a407914bd3ae9d5283f5f1dacf651a34e90e7eafcd60c31a0e9c0bce38a36947** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07417631) (`ctg-observation-nct07417631-2026-07-10-a407914bd3ae`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07417631." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct07417631-dulaglutide-v1 SHA-256: d57d6efa47282c5f5e73f44ed4ab21beeae263c40b94d91f82e557568b0009a8.

---

<a id="clinicaltrials-gov-nct07668336-dulaglutide-v1"></a>

## ClinicalTrials.gov record NCT07668336

> PeptideScanner retained ClinicalTrials.gov record NCT07668336 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was dulaglutide.

- Evidence object: `story:clinicaltrials-gov-nct07668336-dulaglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-11-05
- Source checked: 2026-11-14
- Published by PeptideScanner: 2026-11-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07668336-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct07668336-dulaglutide-v1
- Content SHA-256: `cc26014025d020e00cc827aefa00ef2a136df3fc51500f4d9d612d9489a589b0`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT07668336 ([`ctg-observation-nct07668336-2026-11-05-a5a477ad62ee`](#source-ctg-observation-nct07668336-2026-11-05-a5a477ad62ee))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07668336 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct07668336-2026-11-05-a5a477ad62ee`](#source-ctg-observation-nct07668336-2026-11-05-a5a477ad62ee))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07668336 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was dulaglutide. ([`ctg-observation-nct07668336-2026-11-05-a5a477ad62ee`](#source-ctg-observation-nct07668336-2026-11-05-a5a477ad62ee))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07668336-2026-11-05-a5a477ad62ee`](#source-ctg-observation-nct07668336-2026-11-05-a5a477ad62ee))

### Sources

<a id="source-ctg-observation-nct07668336-2026-11-05-a5a477ad62ee"></a>
- **ClinicalTrials.gov record NCT07668336 · retained source version 2026-11-05:a5a477ad62ee46cac424751f5d51f492f8b133a0e184f5dbb3c7e93f53b20a43** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07668336) (`ctg-observation-nct07668336-2026-11-05-a5a477ad62ee`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07668336." Version 1, published 2026-11-14. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#clinicaltrials-gov-nct07668336-dulaglutide-v1 SHA-256: cc26014025d020e00cc827aefa00ef2a136df3fc51500f4d9d612d9489a589b0.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v10-v1"></a>

## Dulaglutide DailyMed SPL version 10

> DailyMed lists Structured Product Labeling version 10 for the reviewed Dulaglutide label family with a published date of 2015-01-29. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v10:v1`
- Evidence domain: Regulatory
- Date in source: 2015-01-29
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v10/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v10-v1
- Content SHA-256: `adfa3ed40cab1a697f173e941ba41724ffca33186959312ebd4b08e4f0f457a1`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 10 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v10-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v10-history))

#### Summary

DailyMed lists Structured Product Labeling version 10 for the reviewed Dulaglutide label family with a published date of 2015-01-29. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v10-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v10-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 10 for the reviewed Dulaglutide label family with a published date of 2015-01-29. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v10-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v10-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v10-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v10-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v10-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 10 · published 2015-01-29 · retained ZIP SHA-256 f16a5e3cfc000951f9fafcbef849a33ec2f7ef89f391ac72885d4a7a4da0fc55** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=10) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v10-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 10." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v10-v1 SHA-256: adfa3ed40cab1a697f173e941ba41724ffca33186959312ebd4b08e4f0f457a1.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v11-v1"></a>

## Dulaglutide DailyMed SPL version 11

> DailyMed lists Structured Product Labeling version 11 for the reviewed Dulaglutide label family with a published date of 2015-03-17. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v11:v1`
- Evidence domain: Regulatory
- Date in source: 2015-03-17
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v11/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v11-v1
- Content SHA-256: `1a3dd32ddc46331cff6d720156d7e326bb00ecf1be1207bb7664af5d894aeaaf`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 11 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v11-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v11-history))

#### Summary

DailyMed lists Structured Product Labeling version 11 for the reviewed Dulaglutide label family with a published date of 2015-03-17. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v11-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v11-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 11 for the reviewed Dulaglutide label family with a published date of 2015-03-17. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v11-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v11-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v11-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v11-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v11-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 11 · published 2015-03-17 · retained ZIP SHA-256 3aa8b98ff5b50cec28535191608eaa445872fae18521a5cac6bd18ff5c720252** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=11) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v11-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 11." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v11-v1 SHA-256: 1a3dd32ddc46331cff6d720156d7e326bb00ecf1be1207bb7664af5d894aeaaf.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v12-v1"></a>

## Dulaglutide DailyMed SPL version 12

> DailyMed lists Structured Product Labeling version 12 for the reviewed Dulaglutide label family with a published date of 2015-06-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v12:v1`
- Evidence domain: Regulatory
- Date in source: 2015-06-08
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v12/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v12-v1
- Content SHA-256: `e80a3350f5c81dd54f0c1eb8daf426cefc36fbf81e97fc27f42cfe6e73e283c4`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 12 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v12-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v12-history))

#### Summary

DailyMed lists Structured Product Labeling version 12 for the reviewed Dulaglutide label family with a published date of 2015-06-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v12-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v12-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 12 for the reviewed Dulaglutide label family with a published date of 2015-06-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v12-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v12-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v12-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v12-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v12-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 12 · published 2015-06-08 · retained ZIP SHA-256 a3369b679e5d84feb6c195557675bb04e848e19c2c222819d34ec53cd755c684** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=12) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v12-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 12." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v12-v1 SHA-256: e80a3350f5c81dd54f0c1eb8daf426cefc36fbf81e97fc27f42cfe6e73e283c4.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v13-v1"></a>

## Dulaglutide DailyMed SPL version 13

> DailyMed lists Structured Product Labeling version 13 for the reviewed Dulaglutide label family with a published date of 2015-11-17. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v13:v1`
- Evidence domain: Regulatory
- Date in source: 2015-11-17
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v13/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v13-v1
- Content SHA-256: `2bb3e00a69db07be30b87e25197f19254db0f8cca51ce62689496f085c64af56`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 13 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v13-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v13-history))

#### Summary

DailyMed lists Structured Product Labeling version 13 for the reviewed Dulaglutide label family with a published date of 2015-11-17. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v13-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v13-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 13 for the reviewed Dulaglutide label family with a published date of 2015-11-17. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v13-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v13-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v13-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v13-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v13-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 13 · published 2015-11-17 · retained ZIP SHA-256 3fb3c4f84e3c766a5adaf78b594b3abdb02894cf552fb56275838a2537933b2b** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=13) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v13-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 13." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v13-v1 SHA-256: 2bb3e00a69db07be30b87e25197f19254db0f8cca51ce62689496f085c64af56.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v16-v1"></a>

## Dulaglutide DailyMed SPL version 16

> DailyMed lists Structured Product Labeling version 16 for the reviewed Dulaglutide label family with a published date of 2016-11-25. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v16:v1`
- Evidence domain: Regulatory
- Date in source: 2016-11-25
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v16/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v16-v1
- Content SHA-256: `a05af91303ec75ab565d850eaf4e50b78118bfd15b567ee866fa9782a55062ad`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 16 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v16-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v16-history))

#### Summary

DailyMed lists Structured Product Labeling version 16 for the reviewed Dulaglutide label family with a published date of 2016-11-25. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v16-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v16-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 16 for the reviewed Dulaglutide label family with a published date of 2016-11-25. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v16-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v16-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v16-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v16-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v16-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 16 · published 2016-11-25 · retained ZIP SHA-256 a35475f8d36e9e46d238723a086d65325ef920374a5b39d8a9ef812f25088449** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=16) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v16-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 16." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v16-v1 SHA-256: a05af91303ec75ab565d850eaf4e50b78118bfd15b567ee866fa9782a55062ad.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v17-v1"></a>

## Dulaglutide DailyMed SPL version 17

> DailyMed lists Structured Product Labeling version 17 for the reviewed Dulaglutide label family with a published date of 2016-12-21. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v17:v1`
- Evidence domain: Regulatory
- Date in source: 2016-12-21
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v17/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v17-v1
- Content SHA-256: `82a78978d610ede21d11e157a503b9e79cf9dc4988ad61ccf381f87b5f8a04ce`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 17 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v17-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v17-history))

#### Summary

DailyMed lists Structured Product Labeling version 17 for the reviewed Dulaglutide label family with a published date of 2016-12-21. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v17-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v17-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 17 for the reviewed Dulaglutide label family with a published date of 2016-12-21. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v17-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v17-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v17-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v17-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v17-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 17 · published 2016-12-21 · retained ZIP SHA-256 e76836996c33b672fa39f04e688cbd64ee4b4e5ca1ba5ef3f2627931a792fae3** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=17) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v17-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 17." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v17-v1 SHA-256: 82a78978d610ede21d11e157a503b9e79cf9dc4988ad61ccf381f87b5f8a04ce.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v19-v1"></a>

## Dulaglutide DailyMed SPL version 19

> DailyMed lists Structured Product Labeling version 19 for the reviewed Dulaglutide label family with a published date of 2017-02-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v19:v1`
- Evidence domain: Regulatory
- Date in source: 2017-02-06
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v19/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v19-v1
- Content SHA-256: `d5404661885b2708b7b94e5e5ac501bb1aea9c42071fcaf3e6932e2045704846`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 19 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v19-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v19-history))

#### Summary

DailyMed lists Structured Product Labeling version 19 for the reviewed Dulaglutide label family with a published date of 2017-02-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v19-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v19-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 19 for the reviewed Dulaglutide label family with a published date of 2017-02-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v19-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v19-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v19-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v19-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v19-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 19 · published 2017-02-06 · retained ZIP SHA-256 91c24e5c8e013ba9f548bd0d76ccf6d139b354fbbfa6e1e91f85f1ae1cdf7249** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=19) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v19-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 19." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v19-v1 SHA-256: d5404661885b2708b7b94e5e5ac501bb1aea9c42071fcaf3e6932e2045704846.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v21-v1"></a>

## Dulaglutide DailyMed SPL version 21

> DailyMed lists Structured Product Labeling version 21 for the reviewed Dulaglutide label family with a published date of 2017-06-28. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v21:v1`
- Evidence domain: Regulatory
- Date in source: 2017-06-28
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v21/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v21-v1
- Content SHA-256: `88b9a86b35b418b122d2ca2093e1fd62d3bbd06cba006950a16953b2041c337b`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 21 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v21-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v21-history))

#### Summary

DailyMed lists Structured Product Labeling version 21 for the reviewed Dulaglutide label family with a published date of 2017-06-28. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v21-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v21-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 21 for the reviewed Dulaglutide label family with a published date of 2017-06-28. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v21-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v21-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v21-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v21-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v21-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 21 · published 2017-06-28 · retained ZIP SHA-256 9a0c85a406a960c9ed7bcea0f26a2e7b5748053591149dc2ef9ec9b3ca263354** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=21) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v21-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 21." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v21-v1 SHA-256: 88b9a86b35b418b122d2ca2093e1fd62d3bbd06cba006950a16953b2041c337b.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v22-v1"></a>

## Dulaglutide DailyMed SPL version 22

> DailyMed lists Structured Product Labeling version 22 for the reviewed Dulaglutide label family with a published date of 2017-08-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v22:v1`
- Evidence domain: Regulatory
- Date in source: 2017-08-16
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v22/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v22-v1
- Content SHA-256: `5c6d76925d649b24347b3cf15f9adaa7a43437d61cdd309efef5eb8440c8b0c9`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 22 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v22-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v22-history))

#### Summary

DailyMed lists Structured Product Labeling version 22 for the reviewed Dulaglutide label family with a published date of 2017-08-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v22-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v22-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 22 for the reviewed Dulaglutide label family with a published date of 2017-08-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v22-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v22-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v22-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v22-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v22-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 22 · published 2017-08-16 · retained ZIP SHA-256 c24595f47040b5ba3c20c6b723f300413516c965254d0f3f9b1cff9ce4c5fe9c** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=22) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v22-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 22." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v22-v1 SHA-256: 5c6d76925d649b24347b3cf15f9adaa7a43437d61cdd309efef5eb8440c8b0c9.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v23-v1"></a>

## Dulaglutide DailyMed SPL version 23

> DailyMed lists Structured Product Labeling version 23 for the reviewed Dulaglutide label family with a published date of 2017-09-01. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v23:v1`
- Evidence domain: Regulatory
- Date in source: 2017-09-01
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v23/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v23-v1
- Content SHA-256: `5654f2c1be02ffff21ddfbb0e08e1e86ea744e6e695d785f8c062782d7344fff`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 23 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v23-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v23-history))

#### Summary

DailyMed lists Structured Product Labeling version 23 for the reviewed Dulaglutide label family with a published date of 2017-09-01. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v23-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v23-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 23 for the reviewed Dulaglutide label family with a published date of 2017-09-01. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v23-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v23-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v23-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v23-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v23-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 23 · published 2017-09-01 · retained ZIP SHA-256 7120b5ea3f3c7ce550a25c866d5f5e40e20265a82d05047250c5fd8e464b477c** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=23) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v23-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 23." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v23-v1 SHA-256: 5654f2c1be02ffff21ddfbb0e08e1e86ea744e6e695d785f8c062782d7344fff.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v25-v1"></a>

## Dulaglutide DailyMed SPL version 25

> DailyMed lists Structured Product Labeling version 25 for the reviewed Dulaglutide label family with a published date of 2017-10-23. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v25:v1`
- Evidence domain: Regulatory
- Date in source: 2017-10-23
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v25/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v25-v1
- Content SHA-256: `f0318163bfbde4385f02d4095ac6a324e1b72a5343f4430dcf56132a6d3967d0`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 25 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v25-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v25-history))

#### Summary

DailyMed lists Structured Product Labeling version 25 for the reviewed Dulaglutide label family with a published date of 2017-10-23. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v25-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v25-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 25 for the reviewed Dulaglutide label family with a published date of 2017-10-23. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v25-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v25-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v25-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v25-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v25-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 25 · published 2017-10-23 · retained ZIP SHA-256 0dfadf61bfe351eee176748862898045483cf0d98672aeeb61774ac2e1329e68** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=25) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v25-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 25." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v25-v1 SHA-256: f0318163bfbde4385f02d4095ac6a324e1b72a5343f4430dcf56132a6d3967d0.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v28-v1"></a>

## Dulaglutide DailyMed SPL version 28

> DailyMed lists Structured Product Labeling version 28 for the reviewed Dulaglutide label family with a published date of 2018-07-13. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v28:v1`
- Evidence domain: Regulatory
- Date in source: 2018-07-13
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v28/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v28-v1
- Content SHA-256: `c728402dfa11b3a51e7271cb6328f4308ddb5a576d79c403dde90ebb3cf9778d`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 28 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v28-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v28-history))

#### Summary

DailyMed lists Structured Product Labeling version 28 for the reviewed Dulaglutide label family with a published date of 2018-07-13. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v28-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v28-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 28 for the reviewed Dulaglutide label family with a published date of 2018-07-13. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v28-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v28-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v28-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v28-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v28-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 28 · published 2018-07-13 · retained ZIP SHA-256 d316f87da79d69b4e826cd74837fd100a72e7d378ca1c3a83bd9da022315bac7** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=28) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v28-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 28." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v28-v1 SHA-256: c728402dfa11b3a51e7271cb6328f4308ddb5a576d79c403dde90ebb3cf9778d.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v29-v1"></a>

## Dulaglutide DailyMed SPL version 29

> DailyMed lists Structured Product Labeling version 29 for the reviewed Dulaglutide label family with a published date of 2018-10-11. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v29:v1`
- Evidence domain: Regulatory
- Date in source: 2018-10-11
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v29/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v29-v1
- Content SHA-256: `7ce4f1930cc44b008872f636d4feb1c093c83a09d5ef92a97fb4fea6d52628b2`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 29 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v29-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v29-history))

#### Summary

DailyMed lists Structured Product Labeling version 29 for the reviewed Dulaglutide label family with a published date of 2018-10-11. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v29-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v29-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 29 for the reviewed Dulaglutide label family with a published date of 2018-10-11. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v29-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v29-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v29-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v29-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v29-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 29 · published 2018-10-11 · retained ZIP SHA-256 d7cfe8af40fe0c99ee3d7d1c77ea0f0bc345f3d43f633476ad37f6192e0b4dde** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=29) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v29-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 29." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v29-v1 SHA-256: 7ce4f1930cc44b008872f636d4feb1c093c83a09d5ef92a97fb4fea6d52628b2.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v30-v1"></a>

## Dulaglutide DailyMed SPL version 30

> DailyMed lists Structured Product Labeling version 30 for the reviewed Dulaglutide label family with a published date of 2018-11-07. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v30:v1`
- Evidence domain: Regulatory
- Date in source: 2018-11-07
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v30/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v30-v1
- Content SHA-256: `1e38d94dc10b2518b4561b0ad5d852037c5c7e609a2155395d1a457935824c9b`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 30 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v30-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v30-history))

#### Summary

DailyMed lists Structured Product Labeling version 30 for the reviewed Dulaglutide label family with a published date of 2018-11-07. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v30-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v30-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 30 for the reviewed Dulaglutide label family with a published date of 2018-11-07. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v30-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v30-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v30-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v30-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v30-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 30 · published 2018-11-07 · retained ZIP SHA-256 3b9f60a89d2603c54ab5afe753a5d5c27358e61cac31a291c9261d642e04c1fd** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=30) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v30-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 30." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v30-v1 SHA-256: 1e38d94dc10b2518b4561b0ad5d852037c5c7e609a2155395d1a457935824c9b.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v31-v1"></a>

## Dulaglutide DailyMed SPL version 31

> DailyMed lists Structured Product Labeling version 31 for the reviewed Dulaglutide label family with a published date of 2019-01-24. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v31:v1`
- Evidence domain: Regulatory
- Date in source: 2019-01-24
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v31/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v31-v1
- Content SHA-256: `97e03d22edbbe42edabda42503bf8033c35baa91197dbe47c42758c0195df183`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 31 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v31-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v31-history))

#### Summary

DailyMed lists Structured Product Labeling version 31 for the reviewed Dulaglutide label family with a published date of 2019-01-24. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v31-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v31-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 31 for the reviewed Dulaglutide label family with a published date of 2019-01-24. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v31-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v31-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v31-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v31-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v31-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 31 · published 2019-01-24 · retained ZIP SHA-256 5cc4474b0c98b4be9cf4858a2e702dd1ae6c4055c9512ca6a4f1a3bee41c6ca0** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=31) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v31-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 31." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v31-v1 SHA-256: 97e03d22edbbe42edabda42503bf8033c35baa91197dbe47c42758c0195df183.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v34-v1"></a>

## Dulaglutide DailyMed SPL version 34

> DailyMed lists Structured Product Labeling version 34 for the reviewed Dulaglutide label family with a published date of 2020-01-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v34:v1`
- Evidence domain: Regulatory
- Date in source: 2020-01-02
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v34/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v34-v1
- Content SHA-256: `71fc63828d00a307e6101dadd110ef0bfcc521b91488b87bdc8cdd740d1ceafa`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 34 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v34-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v34-history))

#### Summary

DailyMed lists Structured Product Labeling version 34 for the reviewed Dulaglutide label family with a published date of 2020-01-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v34-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v34-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 34 for the reviewed Dulaglutide label family with a published date of 2020-01-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v34-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v34-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v34-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v34-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v34-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 34 · published 2020-01-02 · retained ZIP SHA-256 e7b90a424a53418562546119237fed25676f8541523dafc4ce8d2c2133352e86** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=34) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v34-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 34." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v34-v1 SHA-256: 71fc63828d00a307e6101dadd110ef0bfcc521b91488b87bdc8cdd740d1ceafa.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v35-v1"></a>

## Dulaglutide DailyMed SPL version 35

> DailyMed lists Structured Product Labeling version 35 for the reviewed Dulaglutide label family with a published date of 2020-03-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v35:v1`
- Evidence domain: Regulatory
- Date in source: 2020-03-06
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v35/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v35-v1
- Content SHA-256: `61417f1fa54c4f9f3a3c998372c86dc9b99c5112d1dba53377ef5e4e78438b6e`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 35 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v35-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v35-history))

#### Summary

DailyMed lists Structured Product Labeling version 35 for the reviewed Dulaglutide label family with a published date of 2020-03-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v35-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v35-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 35 for the reviewed Dulaglutide label family with a published date of 2020-03-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v35-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v35-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v35-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v35-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v35-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 35 · published 2020-03-06 · retained ZIP SHA-256 bd7f577905b75c2ace8a9f87d4c1dd1441dbd923ffadb721571e22f7b5789326** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=35) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v35-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 35." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v35-v1 SHA-256: 61417f1fa54c4f9f3a3c998372c86dc9b99c5112d1dba53377ef5e4e78438b6e.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v36-v1"></a>

## Dulaglutide DailyMed SPL version 36

> DailyMed lists Structured Product Labeling version 36 for the reviewed Dulaglutide label family with a published date of 2020-09-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v36:v1`
- Evidence domain: Regulatory
- Date in source: 2020-09-15
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v36/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v36-v1
- Content SHA-256: `6414061c5b861d9fb2c8df89e109003c5675a415cf523e917024209e22af6a4c`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 36 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v36-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v36-history))

#### Summary

DailyMed lists Structured Product Labeling version 36 for the reviewed Dulaglutide label family with a published date of 2020-09-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v36-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v36-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 36 for the reviewed Dulaglutide label family with a published date of 2020-09-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v36-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v36-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v36-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v36-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v36-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 36 · published 2020-09-15 · retained ZIP SHA-256 539e6219d12ca2a4d1865af248c0875bbdda35a158f816ed4fa921a4eb1456bf** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=36) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v36-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 36." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v36-v1 SHA-256: 6414061c5b861d9fb2c8df89e109003c5675a415cf523e917024209e22af6a4c.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v37-v1"></a>

## Dulaglutide DailyMed SPL version 37

> DailyMed lists Structured Product Labeling version 37 for the reviewed Dulaglutide label family with a published date of 2021-01-25. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v37:v1`
- Evidence domain: Regulatory
- Date in source: 2021-01-25
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v37/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v37-v1
- Content SHA-256: `78dec09d65407392863cb189a90a7efd208031e246a935da2b6ee77cc6a2633d`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 37 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v37-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v37-history))

#### Summary

DailyMed lists Structured Product Labeling version 37 for the reviewed Dulaglutide label family with a published date of 2021-01-25. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v37-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v37-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 37 for the reviewed Dulaglutide label family with a published date of 2021-01-25. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v37-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v37-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v37-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v37-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v37-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 37 · published 2021-01-25 · retained ZIP SHA-256 5d638909b5c01794ec50bad6537e60161f32b063111c378040ddcb87b3b7838f** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=37) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v37-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 37." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v37-v1 SHA-256: 78dec09d65407392863cb189a90a7efd208031e246a935da2b6ee77cc6a2633d.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v38-v1"></a>

## Dulaglutide DailyMed SPL version 38

> DailyMed lists Structured Product Labeling version 38 for the reviewed Dulaglutide label family with a published date of 2021-04-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v38:v1`
- Evidence domain: Regulatory
- Date in source: 2021-04-16
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v38/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v38-v1
- Content SHA-256: `38d55680fc182e46dae5f192b8e1b49569fd28de435f7e182c3055df5c6e97a6`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 38 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v38-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v38-history))

#### Summary

DailyMed lists Structured Product Labeling version 38 for the reviewed Dulaglutide label family with a published date of 2021-04-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v38-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v38-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 38 for the reviewed Dulaglutide label family with a published date of 2021-04-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v38-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v38-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v38-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v38-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v38-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 38 · published 2021-04-16 · retained ZIP SHA-256 ad2115a86edbaeaf41e8466ee7240a20ca7e300bf8840d384f4a5ff1d46ab68e** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=38) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v38-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 38." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v38-v1 SHA-256: 38d55680fc182e46dae5f192b8e1b49569fd28de435f7e182c3055df5c6e97a6.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v39-v1"></a>

## Dulaglutide DailyMed SPL version 39

> DailyMed lists Structured Product Labeling version 39 for the reviewed Dulaglutide label family with a published date of 2021-10-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v39:v1`
- Evidence domain: Regulatory
- Date in source: 2021-10-12
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v39/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v39-v1
- Content SHA-256: `ccc0997ec4af977574bc26c1e1a910e869c936f5b86744bb69e1ac1d2b867400`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 39 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v39-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v39-history))

#### Summary

DailyMed lists Structured Product Labeling version 39 for the reviewed Dulaglutide label family with a published date of 2021-10-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v39-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v39-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 39 for the reviewed Dulaglutide label family with a published date of 2021-10-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v39-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v39-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v39-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v39-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v39-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 39 · published 2021-10-12 · retained ZIP SHA-256 9015d6ba6e5a6c97d8b4edd7363b8b95e9feb7dcc1789756cc0901a0fe9a0b8c** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=39) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v39-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 39." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v39-v1 SHA-256: ccc0997ec4af977574bc26c1e1a910e869c936f5b86744bb69e1ac1d2b867400.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v40-v1"></a>

## Dulaglutide DailyMed SPL version 40

> DailyMed lists Structured Product Labeling version 40 for the reviewed Dulaglutide label family with a published date of 2021-10-18. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v40:v1`
- Evidence domain: Regulatory
- Date in source: 2021-10-18
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v40/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v40-v1
- Content SHA-256: `6aac14229ddc487f458f414e679d9fa52bf375493bd96df0c4def3c4d88d9fb7`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 40 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v40-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v40-history))

#### Summary

DailyMed lists Structured Product Labeling version 40 for the reviewed Dulaglutide label family with a published date of 2021-10-18. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v40-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v40-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 40 for the reviewed Dulaglutide label family with a published date of 2021-10-18. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v40-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v40-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v40-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v40-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v40-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 40 · published 2021-10-18 · retained ZIP SHA-256 536d8c03a151dc9a2c149d9b86b7f1e4fd33f06d6097e71e5a8b9bc3c996b847** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=40) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v40-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 40." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v40-v1 SHA-256: 6aac14229ddc487f458f414e679d9fa52bf375493bd96df0c4def3c4d88d9fb7.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v41-v1"></a>

## Dulaglutide DailyMed SPL version 41

> DailyMed lists Structured Product Labeling version 41 for the reviewed Dulaglutide label family with a published date of 2021-12-09. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v41:v1`
- Evidence domain: Regulatory
- Date in source: 2021-12-09
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v41/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v41-v1
- Content SHA-256: `18f579d31107847e14b1e3bb20977dafa635f212a05f6d0a0327e78284beefbf`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 41 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v41-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v41-history))

#### Summary

DailyMed lists Structured Product Labeling version 41 for the reviewed Dulaglutide label family with a published date of 2021-12-09. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v41-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v41-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 41 for the reviewed Dulaglutide label family with a published date of 2021-12-09. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v41-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v41-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v41-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v41-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v41-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 41 · published 2021-12-09 · retained ZIP SHA-256 24b1da64ecd2b71d7f23ee536f1782ab927cacd19c8ab4f37f1f17f5ee2e0d49** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=41) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v41-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 41." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v41-v1 SHA-256: 18f579d31107847e14b1e3bb20977dafa635f212a05f6d0a0327e78284beefbf.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v42-v1"></a>

## Dulaglutide DailyMed SPL version 42

> DailyMed lists Structured Product Labeling version 42 for the reviewed Dulaglutide label family with a published date of 2022-02-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v42:v1`
- Evidence domain: Regulatory
- Date in source: 2022-02-15
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v42/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v42-v1
- Content SHA-256: `38f97ad992f2f4c08f6751b8ae4480c0d7da62b0539fb6ea8eb015be0c1a6f7d`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 42 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v42-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v42-history))

#### Summary

DailyMed lists Structured Product Labeling version 42 for the reviewed Dulaglutide label family with a published date of 2022-02-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v42-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v42-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 42 for the reviewed Dulaglutide label family with a published date of 2022-02-15. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v42-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v42-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v42-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v42-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v42-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 42 · published 2022-02-15 · retained ZIP SHA-256 397aed59bda368e8de4c6f80eb0aaa3be89c7be6b0780f15e42ef9ea0ff2f35e** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=42) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v42-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 42." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v42-v1 SHA-256: 38f97ad992f2f4c08f6751b8ae4480c0d7da62b0539fb6ea8eb015be0c1a6f7d.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v45-v1"></a>

## Dulaglutide DailyMed SPL version 45

> DailyMed lists Structured Product Labeling version 45 for the reviewed Dulaglutide label family with a published date of 2022-06-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v45:v1`
- Evidence domain: Regulatory
- Date in source: 2022-06-20
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v45/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v45-v1
- Content SHA-256: `ed0cdc2d8167697ce609e17ef087069850943698591752dbacbca55991f91fd9`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 45 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v45-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v45-history))

#### Summary

DailyMed lists Structured Product Labeling version 45 for the reviewed Dulaglutide label family with a published date of 2022-06-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v45-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v45-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 45 for the reviewed Dulaglutide label family with a published date of 2022-06-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v45-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v45-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v45-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v45-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v45-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 45 · published 2022-06-20 · retained ZIP SHA-256 2d5f880044f3e0c093211555b6a02e8439379ba386262ae32f655abd4e22e90f** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=45) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v45-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 45." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v45-v1 SHA-256: ed0cdc2d8167697ce609e17ef087069850943698591752dbacbca55991f91fd9.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v46-v1"></a>

## Dulaglutide DailyMed SPL version 46

> DailyMed lists Structured Product Labeling version 46 for the reviewed Dulaglutide label family with a published date of 2022-11-30. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v46:v1`
- Evidence domain: Regulatory
- Date in source: 2022-11-30
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v46/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v46-v1
- Content SHA-256: `2e16765cc8ff587b6e812ab0b051ed64e1e40449cc77ca337bd815df30663438`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 46 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v46-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v46-history))

#### Summary

DailyMed lists Structured Product Labeling version 46 for the reviewed Dulaglutide label family with a published date of 2022-11-30. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v46-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v46-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 46 for the reviewed Dulaglutide label family with a published date of 2022-11-30. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v46-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v46-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v46-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v46-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v46-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 46 · published 2022-11-30 · retained ZIP SHA-256 7003169bf1d5d5306011c7dfef3d302b19533cd28388d87a3754b887ad6b0ff4** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=46) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v46-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 46." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v46-v1 SHA-256: 2e16765cc8ff587b6e812ab0b051ed64e1e40449cc77ca337bd815df30663438.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v47-v1"></a>

## Dulaglutide DailyMed SPL version 47

> DailyMed lists Structured Product Labeling version 47 for the reviewed Dulaglutide label family with a published date of 2022-12-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v47:v1`
- Evidence domain: Regulatory
- Date in source: 2022-12-08
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v47/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v47-v1
- Content SHA-256: `27e2c24e0465b7ef83652683395eefb5d3799b4c0ecce88ddaecbc5abe86db7d`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 47 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v47-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v47-history))

#### Summary

DailyMed lists Structured Product Labeling version 47 for the reviewed Dulaglutide label family with a published date of 2022-12-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v47-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v47-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 47 for the reviewed Dulaglutide label family with a published date of 2022-12-08. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v47-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v47-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v47-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v47-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v47-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 47 · published 2022-12-08 · retained ZIP SHA-256 c08a885992a56d3f3b2514ea8d0f9225eeaecd5ac2f581c8bacb43305239c966** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=47) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v47-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 47." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v47-v1 SHA-256: 27e2c24e0465b7ef83652683395eefb5d3799b4c0ecce88ddaecbc5abe86db7d.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v48-v1"></a>

## Dulaglutide DailyMed SPL version 48

> DailyMed lists Structured Product Labeling version 48 for the reviewed Dulaglutide label family with a published date of 2023-05-01. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v48:v1`
- Evidence domain: Regulatory
- Date in source: 2023-05-01
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v48/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v48-v1
- Content SHA-256: `50af23f200baac67a783c2cf2aa7a336e8c0a16a08ed71638855b90747a25511`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 48 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v48-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v48-history))

#### Summary

DailyMed lists Structured Product Labeling version 48 for the reviewed Dulaglutide label family with a published date of 2023-05-01. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v48-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v48-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 48 for the reviewed Dulaglutide label family with a published date of 2023-05-01. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v48-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v48-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v48-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v48-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v48-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 48 · published 2023-05-01 · retained ZIP SHA-256 7333e53e034bdaad3151204700285fef9127733ffcdaf45db46f07fd30d5680f** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=48) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v48-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 48." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v48-v1 SHA-256: 50af23f200baac67a783c2cf2aa7a336e8c0a16a08ed71638855b90747a25511.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v49-v1"></a>

## Dulaglutide DailyMed SPL version 49

> DailyMed lists Structured Product Labeling version 49 for the reviewed Dulaglutide label family with a published date of 2023-10-18. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v49:v1`
- Evidence domain: Regulatory
- Date in source: 2023-10-18
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v49/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v49-v1
- Content SHA-256: `2d359524d4f21770e6db8f7e75815486a8496918afd88e6b40a018f03c9cf191`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 49 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v49-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v49-history))

#### Summary

DailyMed lists Structured Product Labeling version 49 for the reviewed Dulaglutide label family with a published date of 2023-10-18. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v49-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v49-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 49 for the reviewed Dulaglutide label family with a published date of 2023-10-18. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v49-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v49-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v49-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v49-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v49-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 49 · published 2023-10-18 · retained ZIP SHA-256 a46b7379b1afdb29c1a0fe35ab591af523be2d4b5313829fd481663302bc88dc** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=49) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v49-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 49." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v49-v1 SHA-256: 2d359524d4f21770e6db8f7e75815486a8496918afd88e6b40a018f03c9cf191.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v4-v1"></a>

## Dulaglutide DailyMed SPL version 4

> DailyMed lists Structured Product Labeling version 4 for the reviewed Dulaglutide label family with a published date of 2014-10-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v4:v1`
- Evidence domain: Regulatory
- Date in source: 2014-10-02
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v4/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v4-v1
- Content SHA-256: `9ef498b5936ebc419c34cdac2e506580a1e826ec9d8303de8a3a41c71bdbb090`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 4 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v4-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v4-history))

#### Summary

DailyMed lists Structured Product Labeling version 4 for the reviewed Dulaglutide label family with a published date of 2014-10-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v4-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v4-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 4 for the reviewed Dulaglutide label family with a published date of 2014-10-02. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v4-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v4-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v4-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v4-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v4-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 4 · published 2014-10-02 · retained ZIP SHA-256 11671d6e9eabe690dbbd89dc7007e73a9f25bf741c4718ea775254085ff1d0d0** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=4) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v4-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 4." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v4-v1 SHA-256: 9ef498b5936ebc419c34cdac2e506580a1e826ec9d8303de8a3a41c71bdbb090.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v51-v1"></a>

## Dulaglutide DailyMed SPL version 51

> DailyMed lists Structured Product Labeling version 51 for the reviewed Dulaglutide label family with a published date of 2024-07-26. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v51:v1`
- Evidence domain: Regulatory
- Date in source: 2024-07-26
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v51/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v51-v1
- Content SHA-256: `f6d50c5d7634677a023ad07a6d259b0418622c5b749d4a2ca0c3fc10a1b5dd14`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 51 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v51-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v51-history))

#### Summary

DailyMed lists Structured Product Labeling version 51 for the reviewed Dulaglutide label family with a published date of 2024-07-26. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v51-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v51-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 51 for the reviewed Dulaglutide label family with a published date of 2024-07-26. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v51-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v51-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v51-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v51-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v51-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 51 · published 2024-07-26 · retained ZIP SHA-256 29141b1012ecb74a12007af8ee7adbf6ad004cd34acb3840160386dd2191d5c7** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=51) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v51-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 51." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v51-v1 SHA-256: f6d50c5d7634677a023ad07a6d259b0418622c5b749d4a2ca0c3fc10a1b5dd14.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v54-v1"></a>

## Dulaglutide DailyMed SPL version 54

> DailyMed lists Structured Product Labeling version 54 for the reviewed Dulaglutide label family with a published date of 2024-11-14. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v54:v1`
- Evidence domain: Regulatory
- Date in source: 2024-11-14
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v54/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v54-v1
- Content SHA-256: `a86d308306cba8234f0b48fc647fb19f2e4ebd69982f5b29f10bfc71044de1e5`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 54 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v54-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v54-history))

#### Summary

DailyMed lists Structured Product Labeling version 54 for the reviewed Dulaglutide label family with a published date of 2024-11-14. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v54-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v54-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 54 for the reviewed Dulaglutide label family with a published date of 2024-11-14. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v54-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v54-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v54-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v54-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v54-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 54 · published 2024-11-14 · retained ZIP SHA-256 4ba30194dbf3b9dcd3dfe09941b6f5e1ab867f061b21c56cc2ab69bdd1f7d366** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=54) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v54-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 54." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v54-v1 SHA-256: a86d308306cba8234f0b48fc647fb19f2e4ebd69982f5b29f10bfc71044de1e5.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v56-v1"></a>

## Dulaglutide DailyMed SPL version 56

> DailyMed lists Structured Product Labeling version 56 for the reviewed Dulaglutide label family with a published date of 2025-06-09. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v56:v1`
- Evidence domain: Regulatory
- Date in source: 2025-06-09
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v56/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v56-v1
- Content SHA-256: `9532dd73ae7e5123e848b01aade5c36715d8b51393d828696b8e5f6799d51436`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 56 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v56-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v56-history))

#### Summary

DailyMed lists Structured Product Labeling version 56 for the reviewed Dulaglutide label family with a published date of 2025-06-09. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v56-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v56-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 56 for the reviewed Dulaglutide label family with a published date of 2025-06-09. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v56-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v56-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v56-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v56-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v56-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 56 · published 2025-06-09 · retained ZIP SHA-256 9cacd61af535bc4386844c149a17bc38d8350934ea177cf23ab29d3b352b1092** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=56) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v56-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 56." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v56-v1 SHA-256: 9532dd73ae7e5123e848b01aade5c36715d8b51393d828696b8e5f6799d51436.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v57-v1"></a>

## Dulaglutide DailyMed SPL version 57

> DailyMed lists Structured Product Labeling version 57 for the reviewed Dulaglutide label family with a published date of 2025-06-30. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v57:v1`
- Evidence domain: Regulatory
- Date in source: 2025-06-30
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v57/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v57-v1
- Content SHA-256: `feb45b7c95115d21e71d16d2b43d5291d934c1e83645babe0b3ba0eac324e4e7`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 57 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v57-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v57-history))

#### Summary

DailyMed lists Structured Product Labeling version 57 for the reviewed Dulaglutide label family with a published date of 2025-06-30. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v57-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v57-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 57 for the reviewed Dulaglutide label family with a published date of 2025-06-30. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v57-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v57-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v57-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v57-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v57-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 57 · published 2025-06-30 · retained ZIP SHA-256 ca68633d203acacb4d286a9a0e04aae3df84695564f5e77727d7c27d9ff39658** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=57) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v57-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 57." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v57-v1 SHA-256: feb45b7c95115d21e71d16d2b43d5291d934c1e83645babe0b3ba0eac324e4e7.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v59-v1"></a>

## Dulaglutide DailyMed SPL version 59

> DailyMed lists Structured Product Labeling version 59 for the reviewed Dulaglutide label family with a published date of 2025-12-22. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v59:v1`
- Evidence domain: Regulatory
- Date in source: 2025-12-22
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v59/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v59-v1
- Content SHA-256: `096b01df8671dd0daf6f70d51975af79beec43802a49a84a573e8c077fbb0c58`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 59 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v59-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v59-history))

#### Summary

DailyMed lists Structured Product Labeling version 59 for the reviewed Dulaglutide label family with a published date of 2025-12-22. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v59-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v59-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 59 for the reviewed Dulaglutide label family with a published date of 2025-12-22. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v59-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v59-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v59-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v59-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v59-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 59 · published 2025-12-22 · retained ZIP SHA-256 49deea60c57004ccd73bf1a3c55723993adcc1966f1aee2e05b827a6d047ce49** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=59) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v59-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 59." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v59-v1 SHA-256: 096b01df8671dd0daf6f70d51975af79beec43802a49a84a573e8c077fbb0c58.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v5-v1"></a>

## Dulaglutide DailyMed SPL version 5

> DailyMed lists Structured Product Labeling version 5 for the reviewed Dulaglutide label family with a published date of 2014-10-22. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v5:v1`
- Evidence domain: Regulatory
- Date in source: 2014-10-22
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v5/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v5-v1
- Content SHA-256: `d7e69c94f9baa5ff52ed18e863a45d1d1893a4ae2f02433b57b774b5445014a0`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 5 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v5-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v5-history))

#### Summary

DailyMed lists Structured Product Labeling version 5 for the reviewed Dulaglutide label family with a published date of 2014-10-22. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v5-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v5-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 5 for the reviewed Dulaglutide label family with a published date of 2014-10-22. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v5-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v5-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v5-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v5-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v5-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 5 · published 2014-10-22 · retained ZIP SHA-256 79e9b45746df69d54efb2b1e4cd390a15d66fcaaf2cdd925235fdbe62a56e2f3** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=5) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v5-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 5." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v5-v1 SHA-256: d7e69c94f9baa5ff52ed18e863a45d1d1893a4ae2f02433b57b774b5445014a0.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v60-v1"></a>

## Dulaglutide DailyMed SPL version 60

> DailyMed lists Structured Product Labeling version 60 for the reviewed Dulaglutide label family with a published date of 2026-03-25. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v60:v1`
- Evidence domain: Regulatory
- Date in source: 2026-03-25
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v60/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v60-v1
- Content SHA-256: `233bd9857cd4f402d74e1faa9a2d3f41c73e44eb90470f2687d4fb1e397c4a7f`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 60 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v60-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v60-history))

#### Summary

DailyMed lists Structured Product Labeling version 60 for the reviewed Dulaglutide label family with a published date of 2026-03-25. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v60-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v60-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 60 for the reviewed Dulaglutide label family with a published date of 2026-03-25. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v60-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v60-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v60-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v60-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v60-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 60 · published 2026-03-25 · retained ZIP SHA-256 e99d651404ff43432653167f5a2fb97afb6b04606393be0daf54e2846001b314** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=60) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v60-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 60." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v60-v1 SHA-256: 233bd9857cd4f402d74e1faa9a2d3f41c73e44eb90470f2687d4fb1e397c4a7f.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v62-v1"></a>

## Dulaglutide DailyMed SPL version 62

> DailyMed lists Structured Product Labeling version 62 for the reviewed Dulaglutide label family with a published date of 2026-08-10. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v62:v1`
- Evidence domain: Regulatory
- Date in source: 2026-08-10
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v62/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v62-v1
- Content SHA-256: `37ecb6555484bea1377c975003336e640568ccec5a19ab39095b6ce17f939417`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 62 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v62-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v62-history))

#### Summary

DailyMed lists Structured Product Labeling version 62 for the reviewed Dulaglutide label family with a published date of 2026-08-10. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v62-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v62-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 62 for the reviewed Dulaglutide label family with a published date of 2026-08-10. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v62-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v62-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v62-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v62-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v62-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 62 · published 2026-08-10 · retained ZIP SHA-256 0be61134741cd12e32e7ea35d42b7ad3d11a0a333b31e08005cf499692d46779** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=62) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v62-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 62." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v62-v1 SHA-256: 37ecb6555484bea1377c975003336e640568ccec5a19ab39095b6ce17f939417.

---

<a id="dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v8-v1"></a>

## Dulaglutide DailyMed SPL version 8

> DailyMed lists Structured Product Labeling version 8 for the reviewed Dulaglutide label family with a published date of 2015-01-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v8:v1`
- Evidence domain: Regulatory
- Date in source: 2015-01-06
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v8/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v8-v1
- Content SHA-256: `bba32dc23ba5d3b0715c2b2394c972a6994ed8d51842b644d92259aaa4756d9e`

### Claims and source pins

#### Headline

Dulaglutide DailyMed SPL version 8 ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v8-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v8-history))

#### Summary

DailyMed lists Structured Product Labeling version 8 for the reviewed Dulaglutide label family with a published date of 2015-01-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v8-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v8-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 8 for the reviewed Dulaglutide label family with a published date of 2015-01-06. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v8-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v8-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v8-history`](#source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v8-history))

### Sources

<a id="source-dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v8-history"></a>
- **DailyMed SPL SET ID 463050bd-2b1c-40f5-b3c3-0a04bb433309 · SPL version 8 · published 2015-01-06 · retained ZIP SHA-256 5c72f3854da1cac6584a20cb55d45eab2dd1255595de84d42e0b058a19e35ed1** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=463050bd-2b1c-40f5-b3c3-0a04bb433309&version=8) (`dailymed-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v8-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide DailyMed SPL version 8." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#dailymed-label-dulaglutide-463050bd-2b1c-40f5-b3c3-0a04bb433309-v8-v1 SHA-256: bba32dc23ba5d3b0715c2b2394c972a6994ed8d51842b644d92259aaa4756d9e.

---

<a id="fda-drugs-bla125469-v1"></a>

## Drugs@FDA application BLA125469

> The official Drugs@FDA dataset lists original submission 1 for BLA 125469 with status AP dated 2014-09-18, and names dulaglutide among the application record's active ingredients.

- Evidence object: `story:fda-drugs-bla125469:v1`
- Evidence domain: Regulatory
- Date in source: 2014-09-18
- Source checked: 2026-08-14
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/fda-drugs-bla125469/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#fda-drugs-bla125469-v1
- Content SHA-256: `e6776d743be7d8f900bc270e826d9bf16b8c260b9bf6c1e5aaded745f87a7e6a`

### Claims and source pins

#### Headline

Drugs@FDA application BLA125469 ([`fda-drugs-bla125469-2014-09-18-c02325f3972c`](#source-fda-drugs-bla125469-2014-09-18-c02325f3972c))

#### Summary

The official Drugs@FDA dataset lists original submission 1 for BLA 125469 with status AP dated 2014-09-18, and names dulaglutide among the application record's active ingredients. ([`fda-drugs-bla125469-2014-09-18-c02325f3972c`](#source-fda-drugs-bla125469-2014-09-18-c02325f3972c))

#### Paragraph 1

The official Drugs@FDA dataset lists original submission 1 for BLA 125469 with status AP dated 2014-09-18, and names dulaglutide among the application record's active ingredients. ([`fda-drugs-bla125469-2014-09-18-c02325f3972c`](#source-fda-drugs-bla125469-2014-09-18-c02325f3972c))

#### Paragraph 2

This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance. ([`fda-drugs-bla125469-2014-09-18-c02325f3972c`](#source-fda-drugs-bla125469-2014-09-18-c02325f3972c))

### Sources

<a id="source-fda-drugs-bla125469-2014-09-18-c02325f3972c"></a>
- **Drugs@FDA application BLA125469 · original submission status AP · 2014-09-18 · dataset 2026-08-13** — Drugs@FDA via openFDA; class A. [Open source](https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22BLA125469%22&limit=1) (`fda-drugs-bla125469-2014-09-18-c02325f3972c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Drugs@FDA application BLA125469." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#fda-drugs-bla125469-v1 SHA-256: e6776d743be7d8f900bc270e826d9bf16b8c260b9bf6c1e5aaded745f87a7e6a.

---

<a id="fda-enforcement-d-0773-2021-v1"></a>

## FDA enforcement report D-0773-2021

> FDA's dated enforcement report D-0773-2021 lists Class II and source status Terminated for Eli Lilly & Company. PeptideScanner connects the report to reviewed application BLA125469 through exact openFDA application-number annotations.

- Evidence object: `story:fda-enforcement-d-0773-2021:v1`
- Evidence domain: Safety
- Date in source: 2021-09-01
- Source checked: 2026-08-25
- Published by PeptideScanner: 2026-08-25
- Story landing page: https://peptidescanner.com/stories/fda-enforcement-d-0773-2021/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#fda-enforcement-d-0773-2021-v1
- Content SHA-256: `6dde2f3bf0b1332c0eb05a95f00c79aefdcf6615a291e36a96a1f2358877101c`

### Claims and source pins

#### Headline

FDA enforcement report D-0773-2021 ([`fda-enforcement-d-0773-2021-93012b091be4`](#source-fda-enforcement-d-0773-2021-93012b091be4))

#### Summary

FDA's dated enforcement report D-0773-2021 lists Class II and source status Terminated for Eli Lilly & Company. PeptideScanner connects the report to reviewed application BLA125469 through exact openFDA application-number annotations. ([`fda-enforcement-d-0773-2021-93012b091be4`](#source-fda-enforcement-d-0773-2021-93012b091be4))

#### Paragraph 1

FDA's dated enforcement report D-0773-2021 lists Class II and source status Terminated for Eli Lilly & Company. PeptideScanner connects the report to reviewed application BLA125469 through exact openFDA application-number annotations. ([`fda-enforcement-d-0773-2021-93012b091be4`](#source-fda-enforcement-d-0773-2021-93012b091be4))

#### Paragraph 2

FDA's source-reported reason is: Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product. ([`fda-enforcement-d-0773-2021-93012b091be4`](#source-fda-enforcement-d-0773-2021-93012b091be4))

#### Paragraph 3

This PeptideScanner lane is a bounded, dated FDA enforcement-report snapshot connected through an exact openFDA application-number annotation. It is not a medical alert or complete recall-lifecycle tracker, does not establish current product or recall status, does not identify affected lots, and does not provide medical guidance. ([`fda-enforcement-d-0773-2021-93012b091be4`](#source-fda-enforcement-d-0773-2021-93012b091be4))

### Sources

<a id="source-fda-enforcement-d-0773-2021-93012b091be4"></a>
- **FDA enforcement report D-0773-2021 · Class II · report date 2021-09-01 · source status Terminated** — FDA enforcement reports via openFDA; class A. [Open source](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0773-2021%22&limit=1) (`fda-enforcement-d-0773-2021-93012b091be4`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited safety or enforcement record. It is not an individualized risk assessment or medical recommendation.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "FDA enforcement report D-0773-2021." Version 1, published 2026-08-25. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#fda-enforcement-d-0773-2021-v1 SHA-256: 6dde2f3bf0b1332c0eb05a95f00c79aefdcf6615a291e36a96a1f2358877101c.

---

<a id="fda-enforcement-d-0884-2022-v1"></a>

## FDA enforcement report D-0884-2022

> FDA's dated enforcement report D-0884-2022 lists Class II and source status Completed for Cardinal Health Inc. PeptideScanner connects the report to reviewed application BLA125469 through exact openFDA application-number annotations.

- Evidence object: `story:fda-enforcement-d-0884-2022:v1`
- Evidence domain: Safety
- Date in source: 2022-05-25
- Source checked: 2026-08-25
- Published by PeptideScanner: 2026-08-25
- Story landing page: https://peptidescanner.com/stories/fda-enforcement-d-0884-2022/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#fda-enforcement-d-0884-2022-v1
- Content SHA-256: `ad84705bb25a61db4e8427d24630679b9af1663cd9afdf8b946d547569408810`

### Claims and source pins

#### Headline

FDA enforcement report D-0884-2022 ([`fda-enforcement-d-0884-2022-4c1bd41f618b`](#source-fda-enforcement-d-0884-2022-4c1bd41f618b))

#### Summary

FDA's dated enforcement report D-0884-2022 lists Class II and source status Completed for Cardinal Health Inc. PeptideScanner connects the report to reviewed application BLA125469 through exact openFDA application-number annotations. ([`fda-enforcement-d-0884-2022-4c1bd41f618b`](#source-fda-enforcement-d-0884-2022-4c1bd41f618b))

#### Paragraph 1

FDA's dated enforcement report D-0884-2022 lists Class II and source status Completed for Cardinal Health Inc. PeptideScanner connects the report to reviewed application BLA125469 through exact openFDA application-number annotations. ([`fda-enforcement-d-0884-2022-4c1bd41f618b`](#source-fda-enforcement-d-0884-2022-4c1bd41f618b))

#### Paragraph 2

FDA's source-reported reason is: TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions ([`fda-enforcement-d-0884-2022-4c1bd41f618b`](#source-fda-enforcement-d-0884-2022-4c1bd41f618b))

#### Paragraph 3

This PeptideScanner lane is a bounded, dated FDA enforcement-report snapshot connected through an exact openFDA application-number annotation. It is not a medical alert or complete recall-lifecycle tracker, does not establish current product or recall status, does not identify affected lots, and does not provide medical guidance. ([`fda-enforcement-d-0884-2022-4c1bd41f618b`](#source-fda-enforcement-d-0884-2022-4c1bd41f618b))

### Sources

<a id="source-fda-enforcement-d-0884-2022-4c1bd41f618b"></a>
- **FDA enforcement report D-0884-2022 · Class II · report date 2022-05-25 · source status Completed** — FDA enforcement reports via openFDA; class A. [Open source](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0884-2022%22&limit=1) (`fda-enforcement-d-0884-2022-4c1bd41f618b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited safety or enforcement record. It is not an individualized risk assessment or medical recommendation.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "FDA enforcement report D-0884-2022." Version 1, published 2026-08-25. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#fda-enforcement-d-0884-2022-v1 SHA-256: ad84705bb25a61db4e8427d24630679b9af1663cd9afdf8b946d547569408810.

---

<a id="federal-register-2016-30399-v1"></a>

## Federal Register notice 2016-30399

> The Federal Register published notice 2016-30399, attributed to FDA and its parent HHS department, on 2016-12-19. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; TRULICITY,” and PeptideScanner's exact reviewed identity mapping connects the document to Dulaglutide.

- Evidence object: `story:federal-register-2016-30399:v1`
- Evidence domain: Regulatory
- Date in source: 2016-12-19
- Source checked: 2026-08-21
- Published by PeptideScanner: 2026-08-21
- Story landing page: https://peptidescanner.com/stories/federal-register-2016-30399/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#federal-register-2016-30399-v1
- Content SHA-256: `e008ba69572b7c096f489542bd86ff5d0d0240e24312e236360ee94cb8a3da73`

### Claims and source pins

#### Headline

Federal Register notice 2016-30399 ([`federal-register-2016-30399-a3b4e20b5382`](#source-federal-register-2016-30399-a3b4e20b5382))

#### Summary

The Federal Register published notice 2016-30399, attributed to FDA and its parent HHS department, on 2016-12-19. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; TRULICITY,” and PeptideScanner's exact reviewed identity mapping connects the document to Dulaglutide. ([`federal-register-2016-30399-a3b4e20b5382`](#source-federal-register-2016-30399-a3b4e20b5382))

#### Paragraph 1

The Federal Register published notice 2016-30399, attributed to FDA and its parent HHS department, on 2016-12-19. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; TRULICITY,” and PeptideScanner's exact reviewed identity mapping connects the document to Dulaglutide. ([`federal-register-2016-30399-a3b4e20b5382`](#source-federal-register-2016-30399-a3b4e20b5382))

#### Paragraph 2

This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use. ([`federal-register-2016-30399-a3b4e20b5382`](#source-federal-register-2016-30399-a3b4e20b5382))

### Sources

<a id="source-federal-register-2016-30399-a3b4e20b5382"></a>
- **Federal Register notice 2016-30399 · published 2016-12-19 · Determination of Regulatory Review Period for Purposes of Patent Extension; TRULICITY** — Federal Register via GovInfo; class A. [Open source](https://www.govinfo.gov/content/pkg/FR-2016-12-19/pdf/2016-30399.pdf) (`federal-register-2016-30399-a3b4e20b5382`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Federal Register notice 2016-30399." Version 1, published 2026-08-21. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#federal-register-2016-30399-v1 SHA-256: e008ba69572b7c096f489542bd86ff5d0d0240e24312e236360ee94cb8a3da73.

---

<a id="pubmed-pmid-25575154-dulaglutide-v1"></a>

## PubMed record PMID 25575154

> PeptideScanner retained PubMed bibliographic metadata for PMID 25575154 at 2026-07-30T21:44:40.387Z. PubMed recorded a metadata revision date of 2015-01-10 and an Entrez history date of 2015-01-10. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-25575154-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2015-01-10
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-25575154-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-25575154-dulaglutide-v1
- Content SHA-256: `44f4b7b90b9fb745f1ac352fbf343f080fd79ced7a761ce28fa0ef8b6bf6e6a9`

### Claims and source pins

#### Headline

PubMed record PMID 25575154 ([`pubmed-observation-pmid-25575154-2015-01-10-083279b4cc6e`](#source-pubmed-observation-pmid-25575154-2015-01-10-083279b4cc6e))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 25575154 at 2026-07-30T21:44:40.387Z. PubMed recorded a metadata revision date of 2015-01-10 and an Entrez history date of 2015-01-10. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-25575154-2015-01-10-083279b4cc6e`](#source-pubmed-observation-pmid-25575154-2015-01-10-083279b4cc6e))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 25575154 at 2026-07-30T21:44:40.387Z. PubMed recorded a metadata revision date of 2015-01-10 and an Entrez history date of 2015-01-10. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-25575154-2015-01-10-083279b4cc6e`](#source-pubmed-observation-pmid-25575154-2015-01-10-083279b4cc6e))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-25575154-2015-01-10-083279b4cc6e`](#source-pubmed-observation-pmid-25575154-2015-01-10-083279b4cc6e))

### Sources

<a id="source-pubmed-observation-pmid-25575154-2015-01-10-083279b4cc6e"></a>
- **PubMed record PMID 25575154 · retained source version 1:2015-01-10:current:083279b4cc6e8d4d346eaef0b43617c5a6d3829c515538f6540c7c2d0032ed49** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/25575154/) (`pubmed-observation-pmid-25575154-2015-01-10-083279b4cc6e`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 25575154." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-25575154-dulaglutide-v1 SHA-256: 44f4b7b90b9fb745f1ac352fbf343f080fd79ced7a761ce28fa0ef8b6bf6e6a9.

---

<a id="pubmed-pmid-25715416-dulaglutide-v1"></a>

## PubMed record PMID 25715416

> PeptideScanner retained PubMed bibliographic metadata for PMID 25715416 at 2026-07-30T21:26:46.054Z. PubMed recorded a metadata revision date of 2017-03-08 and an Entrez history date of 2015-02-26. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-25715416-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2017-03-08
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-25715416-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-25715416-dulaglutide-v1
- Content SHA-256: `9ec0c444a3edaa4489ba8d1a85e2b191ff034bf46ff00183d2db52bf83b342f5`

### Claims and source pins

#### Headline

PubMed record PMID 25715416 ([`pubmed-observation-pmid-25715416-2017-03-08-a830e9e7e0cb`](#source-pubmed-observation-pmid-25715416-2017-03-08-a830e9e7e0cb))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 25715416 at 2026-07-30T21:26:46.054Z. PubMed recorded a metadata revision date of 2017-03-08 and an Entrez history date of 2015-02-26. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-25715416-2017-03-08-a830e9e7e0cb`](#source-pubmed-observation-pmid-25715416-2017-03-08-a830e9e7e0cb))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 25715416 at 2026-07-30T21:26:46.054Z. PubMed recorded a metadata revision date of 2017-03-08 and an Entrez history date of 2015-02-26. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-25715416-2017-03-08-a830e9e7e0cb`](#source-pubmed-observation-pmid-25715416-2017-03-08-a830e9e7e0cb))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-25715416-2017-03-08-a830e9e7e0cb`](#source-pubmed-observation-pmid-25715416-2017-03-08-a830e9e7e0cb))

### Sources

<a id="source-pubmed-observation-pmid-25715416-2017-03-08-a830e9e7e0cb"></a>
- **PubMed record PMID 25715416 · retained source version 1:2017-03-08:current:a830e9e7e0cb57b2288d6383b9267929dc9bd2bfe4ee879f8d14d7f890cb859c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/25715416/) (`pubmed-observation-pmid-25715416-2017-03-08-a830e9e7e0cb`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 25715416." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-25715416-dulaglutide-v1 SHA-256: 9ec0c444a3edaa4489ba8d1a85e2b191ff034bf46ff00183d2db52bf83b342f5.

---

<a id="pubmed-pmid-25860029-dulaglutide-v1"></a>

## PubMed record PMID 25860029

> PeptideScanner retained PubMed bibliographic metadata for PMID 25860029 at 2026-07-30T21:09:16.094Z. PubMed recorded a metadata revision date of 2018-12-03 and an Entrez history date of 2015-04-11. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-25860029-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-12-03
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-25860029-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-25860029-dulaglutide-v1
- Content SHA-256: `3b8779c0a2d36d7206456203b96e60875b800090334f85bf6771fc0f5200b14a`

### Claims and source pins

#### Headline

PubMed record PMID 25860029 ([`pubmed-observation-pmid-25860029-2018-12-03-1de984e425f9`](#source-pubmed-observation-pmid-25860029-2018-12-03-1de984e425f9))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 25860029 at 2026-07-30T21:09:16.094Z. PubMed recorded a metadata revision date of 2018-12-03 and an Entrez history date of 2015-04-11. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-25860029-2018-12-03-1de984e425f9`](#source-pubmed-observation-pmid-25860029-2018-12-03-1de984e425f9))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 25860029 at 2026-07-30T21:09:16.094Z. PubMed recorded a metadata revision date of 2018-12-03 and an Entrez history date of 2015-04-11. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-25860029-2018-12-03-1de984e425f9`](#source-pubmed-observation-pmid-25860029-2018-12-03-1de984e425f9))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-25860029-2018-12-03-1de984e425f9`](#source-pubmed-observation-pmid-25860029-2018-12-03-1de984e425f9))

### Sources

<a id="source-pubmed-observation-pmid-25860029-2018-12-03-1de984e425f9"></a>
- **PubMed record PMID 25860029 · retained source version 1:2018-12-03:current:1de984e425f900e2c4271566b566be17452a978eeb8c00a7bc7513b0c5e6cd48** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/25860029/) (`pubmed-observation-pmid-25860029-2018-12-03-1de984e425f9`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 25860029." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-25860029-dulaglutide-v1 SHA-256: 3b8779c0a2d36d7206456203b96e60875b800090334f85bf6771fc0f5200b14a.

---

<a id="pubmed-pmid-26179454-dulaglutide-v1"></a>

## PubMed record PMID 26179454

> PeptideScanner retained PubMed bibliographic metadata for PMID 26179454 at 2026-07-30T21:35:57.004Z. PubMed recorded a metadata revision date of 2016-12-30 and an Entrez history date of 2015-07-17. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-26179454-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2016-12-30
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-26179454-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-26179454-dulaglutide-v1
- Content SHA-256: `920c8b17e6f9dc9adcb2e4d016ab4c332cfe14eee91c887e40042dc0a6bb2f26`

### Claims and source pins

#### Headline

PubMed record PMID 26179454 ([`pubmed-observation-pmid-26179454-2016-12-30-099c9377d924`](#source-pubmed-observation-pmid-26179454-2016-12-30-099c9377d924))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 26179454 at 2026-07-30T21:35:57.004Z. PubMed recorded a metadata revision date of 2016-12-30 and an Entrez history date of 2015-07-17. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-26179454-2016-12-30-099c9377d924`](#source-pubmed-observation-pmid-26179454-2016-12-30-099c9377d924))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 26179454 at 2026-07-30T21:35:57.004Z. PubMed recorded a metadata revision date of 2016-12-30 and an Entrez history date of 2015-07-17. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-26179454-2016-12-30-099c9377d924`](#source-pubmed-observation-pmid-26179454-2016-12-30-099c9377d924))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-26179454-2016-12-30-099c9377d924`](#source-pubmed-observation-pmid-26179454-2016-12-30-099c9377d924))

### Sources

<a id="source-pubmed-observation-pmid-26179454-2016-12-30-099c9377d924"></a>
- **PubMed record PMID 26179454 · retained source version 1:2016-12-30:current:099c9377d9244ca6bab9870ec4571231d1ce71465c6e23dd77cd5c5ab4054d0b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/26179454/) (`pubmed-observation-pmid-26179454-2016-12-30-099c9377d924`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 26179454." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-26179454-dulaglutide-v1 SHA-256: 920c8b17e6f9dc9adcb2e4d016ab4c332cfe14eee91c887e40042dc0a6bb2f26.

---

<a id="pubmed-pmid-27200592-dulaglutide-v1"></a>

## PubMed record PMID 27200592

> PeptideScanner retained PubMed bibliographic metadata for PMID 27200592 at 2026-07-30T21:38:23.144Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-27200592-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2016-05-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-27200592-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-27200592-dulaglutide-v1
- Content SHA-256: `03f077ac974378ad6fded226a6bacccdc4d827eae08cc32363437c17c867f783`

### Claims and source pins

#### Headline

PubMed record PMID 27200592 ([`pubmed-observation-pmid-27200592-2016-05-21-6d00bdfedaf7`](#source-pubmed-observation-pmid-27200592-2016-05-21-6d00bdfedaf7))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 27200592 at 2026-07-30T21:38:23.144Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-27200592-2016-05-21-6d00bdfedaf7`](#source-pubmed-observation-pmid-27200592-2016-05-21-6d00bdfedaf7))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 27200592 at 2026-07-30T21:38:23.144Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-27200592-2016-05-21-6d00bdfedaf7`](#source-pubmed-observation-pmid-27200592-2016-05-21-6d00bdfedaf7))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-27200592-2016-05-21-6d00bdfedaf7`](#source-pubmed-observation-pmid-27200592-2016-05-21-6d00bdfedaf7))

### Sources

<a id="source-pubmed-observation-pmid-27200592-2016-05-21-6d00bdfedaf7"></a>
- **PubMed record PMID 27200592 · retained source version 1:2016-05-21:current:6d00bdfedaf71a46034ed4a9d01b62f52a76017380f0f20ef63c1145ddaa0a84** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/27200592/) (`pubmed-observation-pmid-27200592-2016-05-21-6d00bdfedaf7`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 27200592." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-27200592-dulaglutide-v1 SHA-256: 03f077ac974378ad6fded226a6bacccdc4d827eae08cc32363437c17c867f783.

---

<a id="pubmed-pmid-27200698-dulaglutide-v1"></a>

## PubMed record PMID 27200698

> PeptideScanner retained PubMed bibliographic metadata for PMID 27200698 at 2026-07-30T21:38:23.145Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-27200698-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2016-05-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-27200698-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-27200698-dulaglutide-v1
- Content SHA-256: `2b680909dafa89cef30b07bdd7d33e62c5253e3fd08ae55589773958a1752359`

### Claims and source pins

#### Headline

PubMed record PMID 27200698 ([`pubmed-observation-pmid-27200698-2016-05-21-90be5cd02cce`](#source-pubmed-observation-pmid-27200698-2016-05-21-90be5cd02cce))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 27200698 at 2026-07-30T21:38:23.145Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-27200698-2016-05-21-90be5cd02cce`](#source-pubmed-observation-pmid-27200698-2016-05-21-90be5cd02cce))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 27200698 at 2026-07-30T21:38:23.145Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-27200698-2016-05-21-90be5cd02cce`](#source-pubmed-observation-pmid-27200698-2016-05-21-90be5cd02cce))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-27200698-2016-05-21-90be5cd02cce`](#source-pubmed-observation-pmid-27200698-2016-05-21-90be5cd02cce))

### Sources

<a id="source-pubmed-observation-pmid-27200698-2016-05-21-90be5cd02cce"></a>
- **PubMed record PMID 27200698 · retained source version 1:2016-05-21:current:90be5cd02cceb3dde79f8c1292929ab8ae3d0ba7177d59cc93448e22382ac87c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/27200698/) (`pubmed-observation-pmid-27200698-2016-05-21-90be5cd02cce`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 27200698." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-27200698-dulaglutide-v1 SHA-256: 2b680909dafa89cef30b07bdd7d33e62c5253e3fd08ae55589773958a1752359.

---

<a id="pubmed-pmid-29094890-dulaglutide-v1"></a>

## Dulaglutide (Trulicity) for Type 2 Diabetes Mellitus.

> PubMed lists PMID 29094890 in American family physician as Journal Article, with publication-date metadata of 2017-10-15 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-29094890-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-29094890-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-29094890-dulaglutide-v1
- Content SHA-256: `c79869d132cd5568d30c9b9a19ace70f9fd211434b12e721822394fc03604113`

### Claims and source pins

#### Headline

Dulaglutide (Trulicity) for Type 2 Diabetes Mellitus. ([`pubmed-observation-pmid-29094890-2026-01-27-d3aed4b55955`](#source-pubmed-observation-pmid-29094890-2026-01-27-d3aed4b55955))

#### Summary

PubMed lists PMID 29094890 in American family physician as Journal Article, with publication-date metadata of 2017-10-15 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29094890-2026-01-27-d3aed4b55955`](#source-pubmed-observation-pmid-29094890-2026-01-27-d3aed4b55955))

#### Paragraph 1

PubMed lists PMID 29094890 in American family physician as Journal Article, with publication-date metadata of 2017-10-15 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-29094890-2026-01-27-d3aed4b55955`](#source-pubmed-observation-pmid-29094890-2026-01-27-d3aed4b55955))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-29094890-2026-01-27-d3aed4b55955`](#source-pubmed-observation-pmid-29094890-2026-01-27-d3aed4b55955))

### Sources

<a id="source-pubmed-observation-pmid-29094890-2026-01-27-d3aed4b55955"></a>
- **Dulaglutide (Trulicity) for Type 2 Diabetes Mellitus. · retained source version 1:2026-01-27:current:d3aed4b559553ed201245c97643feda3aa51ead80868a13c328b3360b527b4d7** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/29094890/) (`pubmed-observation-pmid-29094890-2026-01-27-d3aed4b55955`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide (Trulicity) for Type 2 Diabetes Mellitus." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-29094890-dulaglutide-v1 SHA-256: c79869d132cd5568d30c9b9a19ace70f9fd211434b12e721822394fc03604113.

---

<a id="pubmed-pmid-29525225-dulaglutide-v1"></a>

## PubMed record PMID 29525225

> PeptideScanner retained PubMed bibliographic metadata for PMID 29525225 at 2026-07-30T21:09:28.294Z. PubMed recorded a metadata revision date of 2018-10-24 and an Entrez history date of 2018-03-12. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-29525225-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-10-24
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-29525225-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-29525225-dulaglutide-v1
- Content SHA-256: `628fdb9cbc2207a54dfd731f26b9c4c2cde16c29d73542f97ea4f3892a72bde2`

### Claims and source pins

#### Headline

PubMed record PMID 29525225 ([`pubmed-observation-pmid-29525225-2018-10-24-f6d7ccf538ed`](#source-pubmed-observation-pmid-29525225-2018-10-24-f6d7ccf538ed))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 29525225 at 2026-07-30T21:09:28.294Z. PubMed recorded a metadata revision date of 2018-10-24 and an Entrez history date of 2018-03-12. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-29525225-2018-10-24-f6d7ccf538ed`](#source-pubmed-observation-pmid-29525225-2018-10-24-f6d7ccf538ed))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 29525225 at 2026-07-30T21:09:28.294Z. PubMed recorded a metadata revision date of 2018-10-24 and an Entrez history date of 2018-03-12. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-29525225-2018-10-24-f6d7ccf538ed`](#source-pubmed-observation-pmid-29525225-2018-10-24-f6d7ccf538ed))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-29525225-2018-10-24-f6d7ccf538ed`](#source-pubmed-observation-pmid-29525225-2018-10-24-f6d7ccf538ed))

### Sources

<a id="source-pubmed-observation-pmid-29525225-2018-10-24-f6d7ccf538ed"></a>
- **PubMed record PMID 29525225 · retained source version 1:2018-10-24:current:f6d7ccf538ed9cdaa87338d7745bad917523d9eacc02f4cbec93a4e2844a51da** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/29525225/) (`pubmed-observation-pmid-29525225-2018-10-24-f6d7ccf538ed`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 29525225." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-29525225-dulaglutide-v1 SHA-256: 628fdb9cbc2207a54dfd731f26b9c4c2cde16c29d73542f97ea4f3892a72bde2.

---

<a id="pubmed-pmid-29536610-dulaglutide-v1"></a>

## PubMed record PMID 29536610

> PeptideScanner retained PubMed bibliographic metadata for PMID 29536610 at 2026-07-30T21:09:28.294Z. PubMed recorded a metadata revision date of 2018-12-11 and an Entrez history date of 2018-03-15. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-29536610-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-12-11
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-29536610-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-29536610-dulaglutide-v1
- Content SHA-256: `d1d18045324b8ed74c1fa95cae0fc34e2ba4cbc5fa9fb58ba109b93de26c5c90`

### Claims and source pins

#### Headline

PubMed record PMID 29536610 ([`pubmed-observation-pmid-29536610-2018-12-11-ac2bbf0a60a9`](#source-pubmed-observation-pmid-29536610-2018-12-11-ac2bbf0a60a9))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 29536610 at 2026-07-30T21:09:28.294Z. PubMed recorded a metadata revision date of 2018-12-11 and an Entrez history date of 2018-03-15. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-29536610-2018-12-11-ac2bbf0a60a9`](#source-pubmed-observation-pmid-29536610-2018-12-11-ac2bbf0a60a9))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 29536610 at 2026-07-30T21:09:28.294Z. PubMed recorded a metadata revision date of 2018-12-11 and an Entrez history date of 2018-03-15. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-29536610-2018-12-11-ac2bbf0a60a9`](#source-pubmed-observation-pmid-29536610-2018-12-11-ac2bbf0a60a9))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-29536610-2018-12-11-ac2bbf0a60a9`](#source-pubmed-observation-pmid-29536610-2018-12-11-ac2bbf0a60a9))

### Sources

<a id="source-pubmed-observation-pmid-29536610-2018-12-11-ac2bbf0a60a9"></a>
- **PubMed record PMID 29536610 · retained source version 1:2018-12-11:current:ac2bbf0a60a92f2a1e0d373fcb7db9f9e7c91ae06a7081348eb8d8a095d4f13a** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/29536610/) (`pubmed-observation-pmid-29536610-2018-12-11-ac2bbf0a60a9`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 29536610." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-29536610-dulaglutide-v1 SHA-256: d1d18045324b8ed74c1fa95cae0fc34e2ba4cbc5fa9fb58ba109b93de26c5c90.

---

<a id="pubmed-pmid-29852875-dulaglutide-v1"></a>

## PubMed record PMID 29852875

> PeptideScanner retained PubMed bibliographic metadata for PMID 29852875 at 2026-07-30T20:58:13.922Z. PubMed recorded a metadata revision date of 2019-01-03 and an Entrez history date of 2018-06-02. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-29852875-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-01-03
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-29852875-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-29852875-dulaglutide-v1
- Content SHA-256: `42c49c5d33c6475f6cafa300331444c4beea6eec86e15e52ca3006db426f5e6b`

### Claims and source pins

#### Headline

PubMed record PMID 29852875 ([`pubmed-observation-pmid-29852875-2019-01-03-eed713356b99`](#source-pubmed-observation-pmid-29852875-2019-01-03-eed713356b99))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 29852875 at 2026-07-30T20:58:13.922Z. PubMed recorded a metadata revision date of 2019-01-03 and an Entrez history date of 2018-06-02. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-29852875-2019-01-03-eed713356b99`](#source-pubmed-observation-pmid-29852875-2019-01-03-eed713356b99))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 29852875 at 2026-07-30T20:58:13.922Z. PubMed recorded a metadata revision date of 2019-01-03 and an Entrez history date of 2018-06-02. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-29852875-2019-01-03-eed713356b99`](#source-pubmed-observation-pmid-29852875-2019-01-03-eed713356b99))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-29852875-2019-01-03-eed713356b99`](#source-pubmed-observation-pmid-29852875-2019-01-03-eed713356b99))

### Sources

<a id="source-pubmed-observation-pmid-29852875-2019-01-03-eed713356b99"></a>
- **PubMed record PMID 29852875 · retained source version 1:2019-01-03:current:eed713356b99de19f887a11fa7088687cbe9abc2062712b0c08eb1298e3d5a3a** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/29852875/) (`pubmed-observation-pmid-29852875-2019-01-03-eed713356b99`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 29852875." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-29852875-dulaglutide-v1 SHA-256: 42c49c5d33c6475f6cafa300331444c4beea6eec86e15e52ca3006db426f5e6b.

---

<a id="pubmed-pmid-29910025-dulaglutide-v1"></a>

## PubMed record PMID 29910025

> PeptideScanner retained PubMed bibliographic metadata for PMID 29910025 at 2026-07-30T20:57:06.150Z. PubMed recorded a metadata revision date of 2019-02-21 and an Entrez history date of 2018-06-19. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-29910025-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-02-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-29910025-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-29910025-dulaglutide-v1
- Content SHA-256: `1f6d62980d46dbadc8b7b63e79b329f567b9940aadcaca3fb98f3d6151ac2618`

### Claims and source pins

#### Headline

PubMed record PMID 29910025 ([`pubmed-observation-pmid-29910025-2019-02-21-3aa8e573e3b7`](#source-pubmed-observation-pmid-29910025-2019-02-21-3aa8e573e3b7))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 29910025 at 2026-07-30T20:57:06.150Z. PubMed recorded a metadata revision date of 2019-02-21 and an Entrez history date of 2018-06-19. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-29910025-2019-02-21-3aa8e573e3b7`](#source-pubmed-observation-pmid-29910025-2019-02-21-3aa8e573e3b7))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 29910025 at 2026-07-30T20:57:06.150Z. PubMed recorded a metadata revision date of 2019-02-21 and an Entrez history date of 2018-06-19. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-29910025-2019-02-21-3aa8e573e3b7`](#source-pubmed-observation-pmid-29910025-2019-02-21-3aa8e573e3b7))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-29910025-2019-02-21-3aa8e573e3b7`](#source-pubmed-observation-pmid-29910025-2019-02-21-3aa8e573e3b7))

### Sources

<a id="source-pubmed-observation-pmid-29910025-2019-02-21-3aa8e573e3b7"></a>
- **PubMed record PMID 29910025 · retained source version 1:2019-02-21:current:3aa8e573e3b738b170b9202952ecd40a89e452a5ea7933d9eb9ebf9144543976** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/29910025/) (`pubmed-observation-pmid-29910025-2019-02-21-3aa8e573e3b7`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 29910025." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-29910025-dulaglutide-v1 SHA-256: 1f6d62980d46dbadc8b7b63e79b329f567b9940aadcaca3fb98f3d6151ac2618.

---

<a id="pubmed-pmid-30410215-dulaglutide-v1"></a>

## Dulaglutide for type 2 diabetes.

> PubMed lists PMID 30410215 in Australian prescriber as Journal Article, Review, with publication-date metadata of 2018-09-11 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-30410215-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2021-02-06
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-30410215-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-30410215-dulaglutide-v1
- Content SHA-256: `bfef5d9420d3154297ad863943689e2b81b0ea5b91a0cdb17725be737ea96e0b`

### Claims and source pins

#### Headline

Dulaglutide for type 2 diabetes. ([`pubmed-observation-pmid-30410215-2021-02-06-030c2700a1b0`](#source-pubmed-observation-pmid-30410215-2021-02-06-030c2700a1b0))

#### Summary

PubMed lists PMID 30410215 in Australian prescriber as Journal Article, Review, with publication-date metadata of 2018-09-11 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30410215-2021-02-06-030c2700a1b0`](#source-pubmed-observation-pmid-30410215-2021-02-06-030c2700a1b0))

#### Paragraph 1

PubMed lists PMID 30410215 in Australian prescriber as Journal Article, Review, with publication-date metadata of 2018-09-11 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30410215-2021-02-06-030c2700a1b0`](#source-pubmed-observation-pmid-30410215-2021-02-06-030c2700a1b0))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-30410215-2021-02-06-030c2700a1b0`](#source-pubmed-observation-pmid-30410215-2021-02-06-030c2700a1b0))

### Sources

<a id="source-pubmed-observation-pmid-30410215-2021-02-06-030c2700a1b0"></a>
- **Dulaglutide for type 2 diabetes. · retained source version 1:2021-02-06:current:030c2700a1b0ee27b9f47b8ab46a80a1b75ea03424fa17ca65e8052db9a5aae4** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/30410215/) (`pubmed-observation-pmid-30410215-2021-02-06-030c2700a1b0`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide for type 2 diabetes." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-30410215-dulaglutide-v1 SHA-256: bfef5d9420d3154297ad863943689e2b81b0ea5b91a0cdb17725be737ea96e0b.

---

<a id="pubmed-pmid-30565376-dulaglutide-v1"></a>

## Largest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipients.

> PubMed lists PMID 30565376 in Diabetes, obesity & metabolism as Journal Article, with publication-date metadata of 2019-01-20 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-30565376-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-30565376-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-30565376-dulaglutide-v1
- Content SHA-256: `8bf70cb04b72dc955eeeb5a671dc353a4336a1406edf0ee74843609ff4a1cdfd`

### Claims and source pins

#### Headline

Largest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipients. ([`pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de`](#source-pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de))

#### Summary

PubMed lists PMID 30565376 in Diabetes, obesity & metabolism as Journal Article, with publication-date metadata of 2019-01-20 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de`](#source-pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de))

#### Paragraph 1

PubMed lists PMID 30565376 in Diabetes, obesity & metabolism as Journal Article, with publication-date metadata of 2019-01-20 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de`](#source-pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de`](#source-pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de))

### Sources

<a id="source-pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de"></a>
- **Largest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipients. · retained source version 1:2026-01-27:current:146cd4f420de4e52ab70787dcdace04b192b07a912e4bcda9231f7409a90a891** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/30565376/) (`pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Largest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipients." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-30565376-dulaglutide-v1 SHA-256: 8bf70cb04b72dc955eeeb5a671dc353a4336a1406edf0ee74843609ff4a1cdfd.

---

<a id="pubmed-pmid-30762290-dulaglutide-v1"></a>

## Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7).

> PubMed lists PMID 30762290 in Diabetes, obesity & metabolism as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-03-29 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-30762290-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2020-05-29
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-30762290-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-30762290-dulaglutide-v1
- Content SHA-256: `a0fdf322d3fbf15c5ded0266f623d813355f3f4b0f363144b887c85ef4b0c571`

### Claims and source pins

#### Headline

Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7). ([`pubmed-observation-pmid-30762290-2020-05-29-1c7854c801b8`](#source-pubmed-observation-pmid-30762290-2020-05-29-1c7854c801b8))

#### Summary

PubMed lists PMID 30762290 in Diabetes, obesity & metabolism as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-03-29 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30762290-2020-05-29-1c7854c801b8`](#source-pubmed-observation-pmid-30762290-2020-05-29-1c7854c801b8))

#### Paragraph 1

PubMed lists PMID 30762290 in Diabetes, obesity & metabolism as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-03-29 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30762290-2020-05-29-1c7854c801b8`](#source-pubmed-observation-pmid-30762290-2020-05-29-1c7854c801b8))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-30762290-2020-05-29-1c7854c801b8`](#source-pubmed-observation-pmid-30762290-2020-05-29-1c7854c801b8))

### Sources

<a id="source-pubmed-observation-pmid-30762290-2020-05-29-1c7854c801b8"></a>
- **Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7). · retained source version 1:2020-05-29:current:1c7854c801b85a2d6efcac8400f97f59d891b78cb8dd4221d078c139ceccb7e1** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/30762290/) (`pubmed-observation-pmid-30762290-2020-05-29-1c7854c801b8`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7)." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-30762290-dulaglutide-v1 SHA-256: a0fdf322d3fbf15c5ded0266f623d813355f3f4b0f363144b887c85ef4b0c571.

---

<a id="pubmed-pmid-31823494-dulaglutide-v1"></a>

## Dulaglutide-related bullous pemphigoid in a patient with type 2 diabetes: A case report.

> PubMed lists PMID 31823494 in Geriatrics & gerontology international as Case Reports, Letter, with publication-date metadata of 2019-12 (month precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-31823494-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2020-05-11
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-31823494-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-31823494-dulaglutide-v1
- Content SHA-256: `131bf51c99b1c4b7cb481e9d9dd4aaf9580f89d3ccfc5e17b7bd9a4f18554534`

### Claims and source pins

#### Headline

Dulaglutide-related bullous pemphigoid in a patient with type 2 diabetes: A case report. ([`pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80`](#source-pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80))

#### Summary

PubMed lists PMID 31823494 in Geriatrics & gerontology international as Case Reports, Letter, with publication-date metadata of 2019-12 (month precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80`](#source-pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80))

#### Paragraph 1

PubMed lists PMID 31823494 in Geriatrics & gerontology international as Case Reports, Letter, with publication-date metadata of 2019-12 (month precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80`](#source-pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80`](#source-pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80))

### Sources

<a id="source-pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80"></a>
- **Dulaglutide-related bullous pemphigoid in a patient with type 2 diabetes: A case report. · retained source version 1:2020-05-11:current:62a9d2797c800b8c730729cad2690cdc8bde686d630597158feb56a17cd82cac** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/31823494/) (`pubmed-observation-pmid-31823494-2020-05-11-62a9d2797c80`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide-related bullous pemphigoid in a patient with type 2 diabetes: A case report." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-31823494-dulaglutide-v1 SHA-256: 131bf51c99b1c4b7cb481e9d9dd4aaf9580f89d3ccfc5e17b7bd9a4f18554534.

---

<a id="pubmed-pmid-32141343-dulaglutide-v1"></a>

## Comparative study of dulaglutide single-use pen Ateos versus insulin degludec FlexTouch on learning and mock administration time in Japanese patients with type 2 diabetes mellitus - a post-hoc analys…

> PubMed lists PMID 32141343 in Current medical research and opinion as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-03-19 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-32141343-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2021-03-11
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-32141343-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-32141343-dulaglutide-v1
- Content SHA-256: `0b3989810a63e1f68ceff399295f17fdd166cf86366478468c321903ba9a4f1c`

### Claims and source pins

#### Headline

Comparative study of dulaglutide single-use pen Ateos versus insulin degludec FlexTouch on learning and mock administration time in Japanese patients with type 2 diabetes mellitus - a post-hoc analys… ([`pubmed-observation-pmid-32141343-2021-03-11-7452eedf35fd`](#source-pubmed-observation-pmid-32141343-2021-03-11-7452eedf35fd))

#### Summary

PubMed lists PMID 32141343 in Current medical research and opinion as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-03-19 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-32141343-2021-03-11-7452eedf35fd`](#source-pubmed-observation-pmid-32141343-2021-03-11-7452eedf35fd))

#### Paragraph 1

PubMed lists PMID 32141343 in Current medical research and opinion as Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-03-19 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-32141343-2021-03-11-7452eedf35fd`](#source-pubmed-observation-pmid-32141343-2021-03-11-7452eedf35fd))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-32141343-2021-03-11-7452eedf35fd`](#source-pubmed-observation-pmid-32141343-2021-03-11-7452eedf35fd))

### Sources

<a id="source-pubmed-observation-pmid-32141343-2021-03-11-7452eedf35fd"></a>
- **Comparative study of dulaglutide single-use pen Ateos versus insulin degludec FlexTouch on learning and mock administration time in Japanese patients with type 2 diabetes mellitus - a post-hoc analysis. · retained source version 1:2021-03-11:current:7452eedf35fdd99847e07c9f4c6dd02073fe2ae10d60fc7c3f739fe290f936b7** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/32141343/) (`pubmed-observation-pmid-32141343-2021-03-11-7452eedf35fd`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Comparative study of dulaglutide single-use pen Ateos versus insulin degludec FlexTouch on learning and mock administration time in Japanese patients with type 2 diabetes mellitus - a post-hoc analys…." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-32141343-dulaglutide-v1 SHA-256: 0b3989810a63e1f68ceff399295f17fdd166cf86366478468c321903ba9a4f1c.

---

<a id="pubmed-pmid-33144906-dulaglutide-v1"></a>

## A CASE OF MORBILLIFORM DRUG ERUPTION TO DULAGLUTIDE.

> PubMed lists PMID 33144906 in The Journal of clinical and aesthetic dermatology as Journal Article, with publication-date metadata of 2020-04-01 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-33144906-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2020-11-05
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-33144906-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-33144906-dulaglutide-v1
- Content SHA-256: `b18644c0480792644125e4cc3cee6f19b852d8571e6ebac880d56880e41c7650`

### Claims and source pins

#### Headline

A CASE OF MORBILLIFORM DRUG ERUPTION TO DULAGLUTIDE. ([`pubmed-observation-pmid-33144906-2020-11-05-2fd9820446e2`](#source-pubmed-observation-pmid-33144906-2020-11-05-2fd9820446e2))

#### Summary

PubMed lists PMID 33144906 in The Journal of clinical and aesthetic dermatology as Journal Article, with publication-date metadata of 2020-04-01 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-33144906-2020-11-05-2fd9820446e2`](#source-pubmed-observation-pmid-33144906-2020-11-05-2fd9820446e2))

#### Paragraph 1

PubMed lists PMID 33144906 in The Journal of clinical and aesthetic dermatology as Journal Article, with publication-date metadata of 2020-04-01 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-33144906-2020-11-05-2fd9820446e2`](#source-pubmed-observation-pmid-33144906-2020-11-05-2fd9820446e2))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-33144906-2020-11-05-2fd9820446e2`](#source-pubmed-observation-pmid-33144906-2020-11-05-2fd9820446e2))

### Sources

<a id="source-pubmed-observation-pmid-33144906-2020-11-05-2fd9820446e2"></a>
- **A CASE OF MORBILLIFORM DRUG ERUPTION TO DULAGLUTIDE. · retained source version 1:2020-11-05:current:2fd9820446e2bee78fd7c42d0ce0d2d3d6bd719b75e95f279321a37762834646** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/33144906/) (`pubmed-observation-pmid-33144906-2020-11-05-2fd9820446e2`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "A CASE OF MORBILLIFORM DRUG ERUPTION TO DULAGLUTIDE." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-33144906-dulaglutide-v1 SHA-256: b18644c0480792644125e4cc3cee6f19b852d8571e6ebac880d56880e41c7650.

---

<a id="pubmed-pmid-34153270-dulaglutide-v1"></a>

## Dulaglutide for erectile dysfunction in type 2 diabetes.

> PubMed lists PMID 34153270 in The lancet. Diabetes & endocrinology as Journal Article, Comment, with publication-date metadata of 2021-06-18 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-34153270-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2021-08-23
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-34153270-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-34153270-dulaglutide-v1
- Content SHA-256: `2b8ae0d61fe3b8399db4ee5ce0d11a8f706dd2f45343b13ac573b2b38825151f`

### Claims and source pins

#### Headline

Dulaglutide for erectile dysfunction in type 2 diabetes. ([`pubmed-observation-pmid-34153270-2021-08-23-3aff3840d463`](#source-pubmed-observation-pmid-34153270-2021-08-23-3aff3840d463))

#### Summary

PubMed lists PMID 34153270 in The lancet. Diabetes & endocrinology as Journal Article, Comment, with publication-date metadata of 2021-06-18 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34153270-2021-08-23-3aff3840d463`](#source-pubmed-observation-pmid-34153270-2021-08-23-3aff3840d463))

#### Paragraph 1

PubMed lists PMID 34153270 in The lancet. Diabetes & endocrinology as Journal Article, Comment, with publication-date metadata of 2021-06-18 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34153270-2021-08-23-3aff3840d463`](#source-pubmed-observation-pmid-34153270-2021-08-23-3aff3840d463))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-34153270-2021-08-23-3aff3840d463`](#source-pubmed-observation-pmid-34153270-2021-08-23-3aff3840d463))

### Sources

<a id="source-pubmed-observation-pmid-34153270-2021-08-23-3aff3840d463"></a>
- **Dulaglutide for erectile dysfunction in type 2 diabetes. · retained source version 1:2021-08-23:current:3aff3840d46361d94c820fa2de5bc3c8551642fb3daf46c859e1dcda9dfb5356** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/34153270/) (`pubmed-observation-pmid-34153270-2021-08-23-3aff3840d463`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Dulaglutide for erectile dysfunction in type 2 diabetes." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-34153270-dulaglutide-v1 SHA-256: 2b8ae0d61fe3b8399db4ee5ce0d11a8f706dd2f45343b13ac573b2b38825151f.

---

<a id="pubmed-pmid-34861012-dulaglutide-v1"></a>

## Acute Kidney Injury Occurring in a Patient Initiated on Dulaglutide.

> PubMed lists PMID 34861012 in The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians as Journal Article, with publication-date metadata of 2018-06-25 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-34861012-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2021-12-06
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-34861012-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-34861012-dulaglutide-v1
- Content SHA-256: `787ab355520e42e3b50ca744f5037c82dd072650fad85bb0dfa7e908e221e3d7`

### Claims and source pins

#### Headline

Acute Kidney Injury Occurring in a Patient Initiated on Dulaglutide. ([`pubmed-observation-pmid-34861012-2021-12-06-840683304345`](#source-pubmed-observation-pmid-34861012-2021-12-06-840683304345))

#### Summary

PubMed lists PMID 34861012 in The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians as Journal Article, with publication-date metadata of 2018-06-25 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34861012-2021-12-06-840683304345`](#source-pubmed-observation-pmid-34861012-2021-12-06-840683304345))

#### Paragraph 1

PubMed lists PMID 34861012 in The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians as Journal Article, with publication-date metadata of 2018-06-25 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34861012-2021-12-06-840683304345`](#source-pubmed-observation-pmid-34861012-2021-12-06-840683304345))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-34861012-2021-12-06-840683304345`](#source-pubmed-observation-pmid-34861012-2021-12-06-840683304345))

### Sources

<a id="source-pubmed-observation-pmid-34861012-2021-12-06-840683304345"></a>
- **Acute Kidney Injury Occurring in a Patient Initiated on Dulaglutide. · retained source version 1:2021-12-06:current:840683304345ee4ff8f54dc7c9416749e24b5dd4a6d47c7be83eed392190d538** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/34861012/) (`pubmed-observation-pmid-34861012-2021-12-06-840683304345`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Acute Kidney Injury Occurring in a Patient Initiated on Dulaglutide." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-34861012-dulaglutide-v1 SHA-256: 787ab355520e42e3b50ca744f5037c82dd072650fad85bb0dfa7e908e221e3d7.

---

<a id="pubmed-pmid-34866291-dulaglutide-v1"></a>

## Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials.

> PubMed lists PMID 34866291 in Diabetes, obesity & metabolism as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-12-19 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-34866291-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-07-22
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-34866291-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-34866291-dulaglutide-v1
- Content SHA-256: `57741dabc5542fb5f46ae4836900609fe7d8e5ef62c5fca301d2ca1f99055f10`

### Claims and source pins

#### Headline

Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials. ([`pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b`](#source-pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b))

#### Summary

PubMed lists PMID 34866291 in Diabetes, obesity & metabolism as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-12-19 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b`](#source-pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b))

#### Paragraph 1

PubMed lists PMID 34866291 in Diabetes, obesity & metabolism as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-12-19 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b`](#source-pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b`](#source-pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b))

### Sources

<a id="source-pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b"></a>
- **Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials. · retained source version 1:2022-07-22:current:7db9b1636c0bdfea988695e73f8b8cd10f53e725e0626e5fd1e7d100c47688f4** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/34866291/) (`pubmed-observation-pmid-34866291-2022-07-22-7db9b1636c0b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-34866291-dulaglutide-v1 SHA-256: 57741dabc5542fb5f46ae4836900609fe7d8e5ef62c5fca301d2ca1f99055f10.

---

<a id="pubmed-pmid-36136154-dulaglutide-v1"></a>

## A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus.

> PubMed lists PMID 36136154 in Acta diabetologica as Case Reports, Journal Article, with publication-date metadata of 2022-09-22 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-36136154-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-36136154-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-36136154-dulaglutide-v1
- Content SHA-256: `122d1b055b531dd9d3e808be8fece590467252dc82fa06356cdc0cc057d19e06`

### Claims and source pins

#### Headline

A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus. ([`pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6`](#source-pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6))

#### Summary

PubMed lists PMID 36136154 in Acta diabetologica as Case Reports, Journal Article, with publication-date metadata of 2022-09-22 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6`](#source-pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6))

#### Paragraph 1

PubMed lists PMID 36136154 in Acta diabetologica as Case Reports, Journal Article, with publication-date metadata of 2022-09-22 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6`](#source-pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6`](#source-pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6))

### Sources

<a id="source-pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6"></a>
- **A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus. · retained source version 1:2026-01-27:current:aa0c3498cce656b4c069137f7d3d13b3b097c75d989b1fb12ce62aa03c5db4e3** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/36136154/) (`pubmed-observation-pmid-36136154-2026-01-27-aa0c3498cce6`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "A case report on use of dulaglutide during the first weeks of pregnancy in woman affected by type 2 diabetes mellitus." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-36136154-dulaglutide-v1 SHA-256: 122d1b055b531dd9d3e808be8fece590467252dc82fa06356cdc0cc057d19e06.

---

<a id="pubmed-pmid-37743669-dulaglutide-v1"></a>

## PubMed record PMID 37743669

> PeptideScanner retained PubMed bibliographic metadata for PMID 37743669 at 2026-08-10T18:13:32.327Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2023-09-25. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-37743669-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-06
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-37743669-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-37743669-dulaglutide-v1
- Content SHA-256: `5f30947262dbb598bade3fa98a0af61af79900fbce035a97e70a1f211de26d09`

### Claims and source pins

#### Headline

PubMed record PMID 37743669 ([`pubmed-observation-pmid-37743669-2026-07-06-877c60f5e452`](#source-pubmed-observation-pmid-37743669-2026-07-06-877c60f5e452))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 37743669 at 2026-08-10T18:13:32.327Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2023-09-25. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-37743669-2026-07-06-877c60f5e452`](#source-pubmed-observation-pmid-37743669-2026-07-06-877c60f5e452))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 37743669 at 2026-08-10T18:13:32.327Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2023-09-25. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-37743669-2026-07-06-877c60f5e452`](#source-pubmed-observation-pmid-37743669-2026-07-06-877c60f5e452))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-37743669-2026-07-06-877c60f5e452`](#source-pubmed-observation-pmid-37743669-2026-07-06-877c60f5e452))

### Sources

<a id="source-pubmed-observation-pmid-37743669-2026-07-06-877c60f5e452"></a>
- **PubMed record PMID 37743669 · retained source version 1:2026-07-06:current:877c60f5e452b2e0e71239f7acc9b8807899ab477aea1ac321937898f28b15ac** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/37743669/) (`pubmed-observation-pmid-37743669-2026-07-06-877c60f5e452`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 37743669." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-37743669-dulaglutide-v1 SHA-256: 5f30947262dbb598bade3fa98a0af61af79900fbce035a97e70a1f211de26d09.

---

<a id="pubmed-pmid-38600796-dulaglutide-v1"></a>

## PubMed record PMID 38600796

> PeptideScanner retained PubMed bibliographic metadata for PMID 38600796 at 2026-07-30T16:14:06.917Z. PubMed recorded a metadata revision date of 2026-06-19 and an Entrez history date of 2024-04-11. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-38600796-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-19
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38600796-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-38600796-dulaglutide-v1
- Content SHA-256: `1ebea90174b6ace46710d55538061e1007d9c863220054c190c9eb3303eb4e77`

### Claims and source pins

#### Headline

PubMed record PMID 38600796 ([`pubmed-observation-pmid-38600796-2026-06-19-91986b2c7197`](#source-pubmed-observation-pmid-38600796-2026-06-19-91986b2c7197))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 38600796 at 2026-07-30T16:14:06.917Z. PubMed recorded a metadata revision date of 2026-06-19 and an Entrez history date of 2024-04-11. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38600796-2026-06-19-91986b2c7197`](#source-pubmed-observation-pmid-38600796-2026-06-19-91986b2c7197))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 38600796 at 2026-07-30T16:14:06.917Z. PubMed recorded a metadata revision date of 2026-06-19 and an Entrez history date of 2024-04-11. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38600796-2026-06-19-91986b2c7197`](#source-pubmed-observation-pmid-38600796-2026-06-19-91986b2c7197))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38600796-2026-06-19-91986b2c7197`](#source-pubmed-observation-pmid-38600796-2026-06-19-91986b2c7197))

### Sources

<a id="source-pubmed-observation-pmid-38600796-2026-06-19-91986b2c7197"></a>
- **PubMed record PMID 38600796 · retained source version 1:2026-06-19:current:91986b2c71979d82f46c5218ede8526d2d97ae351a1360ca85753d7eb7d3822e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38600796/) (`pubmed-observation-pmid-38600796-2026-06-19-91986b2c7197`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 38600796." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-38600796-dulaglutide-v1 SHA-256: 1ebea90174b6ace46710d55538061e1007d9c863220054c190c9eb3303eb4e77.

---

<a id="pubmed-pmid-38715179-dulaglutide-v1"></a>

## PubMed record PMID 38715179

> PeptideScanner retained PubMed bibliographic metadata for PMID 38715179 at 2026-07-30T16:14:06.944Z. PubMed recorded a metadata revision date of 2026-06-18 and an Entrez history date of 2024-05-07. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-38715179-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38715179-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-38715179-dulaglutide-v1
- Content SHA-256: `f48a7fe9b125802ee237b0c5d9f12a5b34d56067c9517cb2726f56e11dfce4e2`

### Claims and source pins

#### Headline

PubMed record PMID 38715179 ([`pubmed-observation-pmid-38715179-2026-06-18-90b23168db8b`](#source-pubmed-observation-pmid-38715179-2026-06-18-90b23168db8b))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 38715179 at 2026-07-30T16:14:06.944Z. PubMed recorded a metadata revision date of 2026-06-18 and an Entrez history date of 2024-05-07. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38715179-2026-06-18-90b23168db8b`](#source-pubmed-observation-pmid-38715179-2026-06-18-90b23168db8b))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 38715179 at 2026-07-30T16:14:06.944Z. PubMed recorded a metadata revision date of 2026-06-18 and an Entrez history date of 2024-05-07. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38715179-2026-06-18-90b23168db8b`](#source-pubmed-observation-pmid-38715179-2026-06-18-90b23168db8b))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38715179-2026-06-18-90b23168db8b`](#source-pubmed-observation-pmid-38715179-2026-06-18-90b23168db8b))

### Sources

<a id="source-pubmed-observation-pmid-38715179-2026-06-18-90b23168db8b"></a>
- **PubMed record PMID 38715179 · retained source version 1:2026-06-18:current:90b23168db8b434518f721d81e39f069a9180614d2b57b5095523d8e2a2bbd54** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38715179/) (`pubmed-observation-pmid-38715179-2026-06-18-90b23168db8b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 38715179." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-38715179-dulaglutide-v1 SHA-256: f48a7fe9b125802ee237b0c5d9f12a5b34d56067c9517cb2726f56e11dfce4e2.

---

<a id="pubmed-pmid-38719260-dulaglutide-v1"></a>

## PubMed record PMID 38719260

> PeptideScanner retained PubMed bibliographic metadata for PMID 38719260 at 2026-07-30T16:20:36.695Z. PubMed recorded a metadata revision date of 2026-05-07 and an Entrez history date of 2024-05-08. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-38719260-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-05-07
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38719260-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-38719260-dulaglutide-v1
- Content SHA-256: `4896a88f424d84d38054708ab267711deed83c43759b2cf02d3920bf5b697914`

### Claims and source pins

#### Headline

PubMed record PMID 38719260 ([`pubmed-observation-pmid-38719260-2026-05-07-973ab50534a7`](#source-pubmed-observation-pmid-38719260-2026-05-07-973ab50534a7))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 38719260 at 2026-07-30T16:20:36.695Z. PubMed recorded a metadata revision date of 2026-05-07 and an Entrez history date of 2024-05-08. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38719260-2026-05-07-973ab50534a7`](#source-pubmed-observation-pmid-38719260-2026-05-07-973ab50534a7))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 38719260 at 2026-07-30T16:20:36.695Z. PubMed recorded a metadata revision date of 2026-05-07 and an Entrez history date of 2024-05-08. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38719260-2026-05-07-973ab50534a7`](#source-pubmed-observation-pmid-38719260-2026-05-07-973ab50534a7))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38719260-2026-05-07-973ab50534a7`](#source-pubmed-observation-pmid-38719260-2026-05-07-973ab50534a7))

### Sources

<a id="source-pubmed-observation-pmid-38719260-2026-05-07-973ab50534a7"></a>
- **PubMed record PMID 38719260 · retained source version 1:2026-05-07:current:973ab50534a786bfa26342082f94ea43f2efda6608395514d7597714aef578dc** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38719260/) (`pubmed-observation-pmid-38719260-2026-05-07-973ab50534a7`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 38719260." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-38719260-dulaglutide-v1 SHA-256: 4896a88f424d84d38054708ab267711deed83c43759b2cf02d3920bf5b697914.

---

<a id="pubmed-pmid-38871561-dulaglutide-v1"></a>

## PubMed record PMID 38871561

> PeptideScanner retained PubMed bibliographic metadata for PMID 38871561 at 2026-07-30T16:20:38.896Z. PubMed recorded a metadata revision date of 2026-05-13 and an Entrez history date of 2024-06-13. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-38871561-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-05-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38871561-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-38871561-dulaglutide-v1
- Content SHA-256: `8fbd18a55a862d97bce7f9b612a143e1388b77d25601e6876a9b9be096225445`

### Claims and source pins

#### Headline

PubMed record PMID 38871561 ([`pubmed-observation-pmid-38871561-2026-05-13-c1b815212272`](#source-pubmed-observation-pmid-38871561-2026-05-13-c1b815212272))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 38871561 at 2026-07-30T16:20:38.896Z. PubMed recorded a metadata revision date of 2026-05-13 and an Entrez history date of 2024-06-13. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38871561-2026-05-13-c1b815212272`](#source-pubmed-observation-pmid-38871561-2026-05-13-c1b815212272))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 38871561 at 2026-07-30T16:20:38.896Z. PubMed recorded a metadata revision date of 2026-05-13 and an Entrez history date of 2024-06-13. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38871561-2026-05-13-c1b815212272`](#source-pubmed-observation-pmid-38871561-2026-05-13-c1b815212272))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38871561-2026-05-13-c1b815212272`](#source-pubmed-observation-pmid-38871561-2026-05-13-c1b815212272))

### Sources

<a id="source-pubmed-observation-pmid-38871561-2026-05-13-c1b815212272"></a>
- **PubMed record PMID 38871561 · retained source version 1:2026-05-13:current:c1b8152122728a76506729c086a2d2b5cc15edacd182a7ca81fb097653ecff62** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38871561/) (`pubmed-observation-pmid-38871561-2026-05-13-c1b815212272`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 38871561." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-38871561-dulaglutide-v1 SHA-256: 8fbd18a55a862d97bce7f9b612a143e1388b77d25601e6876a9b9be096225445.

---

<a id="pubmed-pmid-38954432-dulaglutide-v1"></a>

## PubMed record PMID 38954432

> PeptideScanner retained PubMed bibliographic metadata for PMID 38954432 at 2026-07-30T16:14:08.766Z. PubMed recorded a metadata revision date of 2026-06-22 and an Entrez history date of 2024-07-02. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-38954432-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-22
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38954432-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-38954432-dulaglutide-v1
- Content SHA-256: `1e3049a6fed44c48add74b8c6e18b3ea0834e8fab8f624e8a2b3887682e5f899`

### Claims and source pins

#### Headline

PubMed record PMID 38954432 ([`pubmed-observation-pmid-38954432-2026-06-22-b15f464d55b3`](#source-pubmed-observation-pmid-38954432-2026-06-22-b15f464d55b3))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 38954432 at 2026-07-30T16:14:08.766Z. PubMed recorded a metadata revision date of 2026-06-22 and an Entrez history date of 2024-07-02. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38954432-2026-06-22-b15f464d55b3`](#source-pubmed-observation-pmid-38954432-2026-06-22-b15f464d55b3))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 38954432 at 2026-07-30T16:14:08.766Z. PubMed recorded a metadata revision date of 2026-06-22 and an Entrez history date of 2024-07-02. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-38954432-2026-06-22-b15f464d55b3`](#source-pubmed-observation-pmid-38954432-2026-06-22-b15f464d55b3))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38954432-2026-06-22-b15f464d55b3`](#source-pubmed-observation-pmid-38954432-2026-06-22-b15f464d55b3))

### Sources

<a id="source-pubmed-observation-pmid-38954432-2026-06-22-b15f464d55b3"></a>
- **PubMed record PMID 38954432 · retained source version 1:2026-06-22:current:b15f464d55b3e7b1ff6945a549d551d5c90f91cfbf0e324ccad5f99700b1743b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38954432/) (`pubmed-observation-pmid-38954432-2026-06-22-b15f464d55b3`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 38954432." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-38954432-dulaglutide-v1 SHA-256: 1e3049a6fed44c48add74b8c6e18b3ea0834e8fab8f624e8a2b3887682e5f899.

---

<a id="pubmed-pmid-39126516-dulaglutide-v1"></a>

## Use of dulaglutide in a pregnant woman with type 2 diabetes until third trimester of pregnancy.

> PubMed lists PMID 39126516 in Acta diabetologica as Journal Article, with publication-date metadata of 2024-08-10 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39126516-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-11-05
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39126516-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-39126516-dulaglutide-v1
- Content SHA-256: `8583b4730d169b1220ab9c829d4a931177217c3ddd48675d0de65c33dd159523`

### Claims and source pins

#### Headline

Use of dulaglutide in a pregnant woman with type 2 diabetes until third trimester of pregnancy. ([`pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601`](#source-pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601))

#### Summary

PubMed lists PMID 39126516 in Acta diabetologica as Journal Article, with publication-date metadata of 2024-08-10 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601`](#source-pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601))

#### Paragraph 1

PubMed lists PMID 39126516 in Acta diabetologica as Journal Article, with publication-date metadata of 2024-08-10 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601`](#source-pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601`](#source-pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601))

### Sources

<a id="source-pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601"></a>
- **Use of dulaglutide in a pregnant woman with type 2 diabetes until third trimester of pregnancy. · retained source version 1:2024-11-05:current:ac3e203c860189e07048cca6ff4027b5b2ccc8713e68d945bd17c01c8584ba4b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39126516/) (`pubmed-observation-pmid-39126516-2024-11-05-ac3e203c8601`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Use of dulaglutide in a pregnant woman with type 2 diabetes until third trimester of pregnancy." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-39126516-dulaglutide-v1 SHA-256: 8583b4730d169b1220ab9c829d4a931177217c3ddd48675d0de65c33dd159523.

---

<a id="pubmed-pmid-39718468-dulaglutide-v1"></a>

## PubMed record PMID 39718468

> PeptideScanner retained PubMed bibliographic metadata for PMID 39718468 at 2026-07-30T16:14:08.915Z. PubMed recorded a metadata revision date of 2026-06-20 and an Entrez history date of 2024-12-24. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-39718468-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-20
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39718468-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-39718468-dulaglutide-v1
- Content SHA-256: `ec351399391b145941eff791cb3c449876e00c697f7b444dc92375537de2c46f`

### Claims and source pins

#### Headline

PubMed record PMID 39718468 ([`pubmed-observation-pmid-39718468-2026-06-20-5a17e7758e08`](#source-pubmed-observation-pmid-39718468-2026-06-20-5a17e7758e08))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 39718468 at 2026-07-30T16:14:08.915Z. PubMed recorded a metadata revision date of 2026-06-20 and an Entrez history date of 2024-12-24. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39718468-2026-06-20-5a17e7758e08`](#source-pubmed-observation-pmid-39718468-2026-06-20-5a17e7758e08))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 39718468 at 2026-07-30T16:14:08.915Z. PubMed recorded a metadata revision date of 2026-06-20 and an Entrez history date of 2024-12-24. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39718468-2026-06-20-5a17e7758e08`](#source-pubmed-observation-pmid-39718468-2026-06-20-5a17e7758e08))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39718468-2026-06-20-5a17e7758e08`](#source-pubmed-observation-pmid-39718468-2026-06-20-5a17e7758e08))

### Sources

<a id="source-pubmed-observation-pmid-39718468-2026-06-20-5a17e7758e08"></a>
- **PubMed record PMID 39718468 · retained source version 1:2026-06-20:current:5a17e7758e08632808966d1c5d4069342afb779322ac617909c923602fa2f861** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39718468/) (`pubmed-observation-pmid-39718468-2026-06-20-5a17e7758e08`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 39718468." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-39718468-dulaglutide-v1 SHA-256: ec351399391b145941eff791cb3c449876e00c697f7b444dc92375537de2c46f.

---

<a id="pubmed-pmid-40536052-dulaglutide-v1"></a>

## PubMed record PMID 40536052

> PeptideScanner retained PubMed bibliographic metadata for PMID 40536052 at 2026-07-30T16:20:41.387Z. PubMed recorded a metadata revision date of 2026-05-04 and an Entrez history date of 2025-06-19. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-40536052-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-05-04
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40536052-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-40536052-dulaglutide-v1
- Content SHA-256: `231e553b739e8349a045490a08b0a41f09a1bce6130eb9d6d0decb298923e6e0`

### Claims and source pins

#### Headline

PubMed record PMID 40536052 ([`pubmed-observation-pmid-40536052-2026-05-04-bcadf0183a10`](#source-pubmed-observation-pmid-40536052-2026-05-04-bcadf0183a10))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 40536052 at 2026-07-30T16:20:41.387Z. PubMed recorded a metadata revision date of 2026-05-04 and an Entrez history date of 2025-06-19. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40536052-2026-05-04-bcadf0183a10`](#source-pubmed-observation-pmid-40536052-2026-05-04-bcadf0183a10))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 40536052 at 2026-07-30T16:20:41.387Z. PubMed recorded a metadata revision date of 2026-05-04 and an Entrez history date of 2025-06-19. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-40536052-2026-05-04-bcadf0183a10`](#source-pubmed-observation-pmid-40536052-2026-05-04-bcadf0183a10))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40536052-2026-05-04-bcadf0183a10`](#source-pubmed-observation-pmid-40536052-2026-05-04-bcadf0183a10))

### Sources

<a id="source-pubmed-observation-pmid-40536052-2026-05-04-bcadf0183a10"></a>
- **PubMed record PMID 40536052 · retained source version 1:2026-05-04:current:bcadf0183a103552d945c72ba46b8b9fac65a5efb2858764ba2cf72d5360c315** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40536052/) (`pubmed-observation-pmid-40536052-2026-05-04-bcadf0183a10`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 40536052." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-40536052-dulaglutide-v1 SHA-256: 231e553b739e8349a045490a08b0a41f09a1bce6130eb9d6d0decb298923e6e0.

---

<a id="pubmed-pmid-40555685-dulaglutide-v1"></a>

## Inequity in adherence to empagliflozin and dulaglutide for type 2 diabetes in Aotearoa New Zealand.

> PubMed lists PMID 40555685 in Diabetes, obesity & metabolism as Letter, with publication-date metadata of 2025-06-24 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-40555685-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-09-11
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40555685-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-40555685-dulaglutide-v1
- Content SHA-256: `433ff854b74665d43a83c1c142701de66ba24062e7fadb7b7ae27b605d7e3587`

### Claims and source pins

#### Headline

Inequity in adherence to empagliflozin and dulaglutide for type 2 diabetes in Aotearoa New Zealand. ([`pubmed-observation-pmid-40555685-2025-09-11-f5bf2127dcc5`](#source-pubmed-observation-pmid-40555685-2025-09-11-f5bf2127dcc5))

#### Summary

PubMed lists PMID 40555685 in Diabetes, obesity & metabolism as Letter, with publication-date metadata of 2025-06-24 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40555685-2025-09-11-f5bf2127dcc5`](#source-pubmed-observation-pmid-40555685-2025-09-11-f5bf2127dcc5))

#### Paragraph 1

PubMed lists PMID 40555685 in Diabetes, obesity & metabolism as Letter, with publication-date metadata of 2025-06-24 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40555685-2025-09-11-f5bf2127dcc5`](#source-pubmed-observation-pmid-40555685-2025-09-11-f5bf2127dcc5))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40555685-2025-09-11-f5bf2127dcc5`](#source-pubmed-observation-pmid-40555685-2025-09-11-f5bf2127dcc5))

### Sources

<a id="source-pubmed-observation-pmid-40555685-2025-09-11-f5bf2127dcc5"></a>
- **Inequity in adherence to empagliflozin and dulaglutide for type 2 diabetes in Aotearoa New Zealand. · retained source version 1:2025-09-11:current:f5bf2127dcc555ad8e0ed58dd45a603534158f4cc97b6d306d6f7cc2312041d7** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40555685/) (`pubmed-observation-pmid-40555685-2025-09-11-f5bf2127dcc5`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Inequity in adherence to empagliflozin and dulaglutide for type 2 diabetes in Aotearoa New Zealand." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-40555685-dulaglutide-v1 SHA-256: 433ff854b74665d43a83c1c142701de66ba24062e7fadb7b7ae27b605d7e3587.

---

<a id="pubmed-pmid-41231281-dulaglutide-v1"></a>

## PubMed record PMID 41231281

> PeptideScanner retained PubMed bibliographic metadata for PMID 41231281 at 2026-07-30T16:23:39.111Z. PubMed recorded a metadata revision date of 2026-03-03 and an Entrez history date of 2025-11-13. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41231281-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-03-03
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41231281-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-41231281-dulaglutide-v1
- Content SHA-256: `4a6a5b9562a49a493630030529d5e9bdf93e1d8798597ca7794cb4afcf099a61`

### Claims and source pins

#### Headline

PubMed record PMID 41231281 ([`pubmed-observation-pmid-41231281-2026-03-03-6fe71bff3a42`](#source-pubmed-observation-pmid-41231281-2026-03-03-6fe71bff3a42))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41231281 at 2026-07-30T16:23:39.111Z. PubMed recorded a metadata revision date of 2026-03-03 and an Entrez history date of 2025-11-13. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41231281-2026-03-03-6fe71bff3a42`](#source-pubmed-observation-pmid-41231281-2026-03-03-6fe71bff3a42))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41231281 at 2026-07-30T16:23:39.111Z. PubMed recorded a metadata revision date of 2026-03-03 and an Entrez history date of 2025-11-13. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41231281-2026-03-03-6fe71bff3a42`](#source-pubmed-observation-pmid-41231281-2026-03-03-6fe71bff3a42))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41231281-2026-03-03-6fe71bff3a42`](#source-pubmed-observation-pmid-41231281-2026-03-03-6fe71bff3a42))

### Sources

<a id="source-pubmed-observation-pmid-41231281-2026-03-03-6fe71bff3a42"></a>
- **PubMed record PMID 41231281 · retained source version 1:2026-03-03:current:6fe71bff3a42cf91af6ee3253baaa66e8910b33f47c0b45c00d2aca0dc5575cc** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41231281/) (`pubmed-observation-pmid-41231281-2026-03-03-6fe71bff3a42`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41231281." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-41231281-dulaglutide-v1 SHA-256: 4a6a5b9562a49a493630030529d5e9bdf93e1d8798597ca7794cb4afcf099a61.

---

<a id="pubmed-pmid-41471386-dulaglutide-v1"></a>

## Production of a Dulaglutide Analogue by Apoptosis-Resistant Chinese Hamster Ovary Cells in a 3-Week Fed-Batch Process.

> PubMed lists PMID 41471386 in Pharmaceuticals (Basel, Switzerland) as Journal Article, with publication-date metadata of 2025-12-16 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41471386-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-03
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41471386-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-41471386-dulaglutide-v1
- Content SHA-256: `285510316c420cfe40ad47de88c8c216cbaff3298950b5e0eee6367fee2e6976`

### Claims and source pins

#### Headline

Production of a Dulaglutide Analogue by Apoptosis-Resistant Chinese Hamster Ovary Cells in a 3-Week Fed-Batch Process. ([`pubmed-observation-pmid-41471386-2026-01-03-d175739d946b`](#source-pubmed-observation-pmid-41471386-2026-01-03-d175739d946b))

#### Summary

PubMed lists PMID 41471386 in Pharmaceuticals (Basel, Switzerland) as Journal Article, with publication-date metadata of 2025-12-16 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41471386-2026-01-03-d175739d946b`](#source-pubmed-observation-pmid-41471386-2026-01-03-d175739d946b))

#### Paragraph 1

PubMed lists PMID 41471386 in Pharmaceuticals (Basel, Switzerland) as Journal Article, with publication-date metadata of 2025-12-16 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41471386-2026-01-03-d175739d946b`](#source-pubmed-observation-pmid-41471386-2026-01-03-d175739d946b))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41471386-2026-01-03-d175739d946b`](#source-pubmed-observation-pmid-41471386-2026-01-03-d175739d946b))

### Sources

<a id="source-pubmed-observation-pmid-41471386-2026-01-03-d175739d946b"></a>
- **Production of a Dulaglutide Analogue by Apoptosis-Resistant Chinese Hamster Ovary Cells in a 3-Week Fed-Batch Process. · retained source version 1:2026-01-03:current:d175739d946bf90c08709844e4b3ab7f1a878cc7eaec47d229f6c041bc8af371** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41471386/) (`pubmed-observation-pmid-41471386-2026-01-03-d175739d946b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Production of a Dulaglutide Analogue by Apoptosis-Resistant Chinese Hamster Ovary Cells in a 3-Week Fed-Batch Process." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-41471386-dulaglutide-v1 SHA-256: 285510316c420cfe40ad47de88c8c216cbaff3298950b5e0eee6367fee2e6976.

---

<a id="pubmed-pmid-41693775-dulaglutide-v1"></a>

## PubMed record PMID 41693775

> PeptideScanner retained PubMed bibliographic metadata for PMID 41693775 at 2026-07-30T16:25:14.309Z. PubMed recorded a metadata revision date of 2026-02-18 and an Entrez history date of 2026-02-16. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41693775-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-02-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41693775-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-41693775-dulaglutide-v1
- Content SHA-256: `6de74d75d430e56679623e096d169c512c09e74d780624a88a2b5add4161b46f`

### Claims and source pins

#### Headline

PubMed record PMID 41693775 ([`pubmed-observation-pmid-41693775-2026-02-18-be7747d759bf`](#source-pubmed-observation-pmid-41693775-2026-02-18-be7747d759bf))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41693775 at 2026-07-30T16:25:14.309Z. PubMed recorded a metadata revision date of 2026-02-18 and an Entrez history date of 2026-02-16. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41693775-2026-02-18-be7747d759bf`](#source-pubmed-observation-pmid-41693775-2026-02-18-be7747d759bf))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41693775 at 2026-07-30T16:25:14.309Z. PubMed recorded a metadata revision date of 2026-02-18 and an Entrez history date of 2026-02-16. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41693775-2026-02-18-be7747d759bf`](#source-pubmed-observation-pmid-41693775-2026-02-18-be7747d759bf))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41693775-2026-02-18-be7747d759bf`](#source-pubmed-observation-pmid-41693775-2026-02-18-be7747d759bf))

### Sources

<a id="source-pubmed-observation-pmid-41693775-2026-02-18-be7747d759bf"></a>
- **PubMed record PMID 41693775 · retained source version 1:2026-02-18:current:be7747d759bf1db775fcc2a5c049104cc05527d9ca82ecdbd96fb657acfa165f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41693775/) (`pubmed-observation-pmid-41693775-2026-02-18-be7747d759bf`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41693775." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-41693775-dulaglutide-v1 SHA-256: 6de74d75d430e56679623e096d169c512c09e74d780624a88a2b5add4161b46f.

---

<a id="pubmed-pmid-41988866-dulaglutide-v1"></a>

## PubMed record PMID 41988866

> PeptideScanner retained PubMed bibliographic metadata for PMID 41988866 at 2026-08-10T18:13:46.880Z. PubMed recorded a metadata revision date of 2026-07-15 and an Entrez history date of 2026-04-16. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41988866-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-15
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41988866-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-41988866-dulaglutide-v1
- Content SHA-256: `bcff13c7988589766775d5c5f018f44735f1253232044b19107134e8b97e9a32`

### Claims and source pins

#### Headline

PubMed record PMID 41988866 ([`pubmed-observation-pmid-41988866-2026-07-15-2e415e8b7252`](#source-pubmed-observation-pmid-41988866-2026-07-15-2e415e8b7252))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41988866 at 2026-08-10T18:13:46.880Z. PubMed recorded a metadata revision date of 2026-07-15 and an Entrez history date of 2026-04-16. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41988866-2026-07-15-2e415e8b7252`](#source-pubmed-observation-pmid-41988866-2026-07-15-2e415e8b7252))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41988866 at 2026-08-10T18:13:46.880Z. PubMed recorded a metadata revision date of 2026-07-15 and an Entrez history date of 2026-04-16. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41988866-2026-07-15-2e415e8b7252`](#source-pubmed-observation-pmid-41988866-2026-07-15-2e415e8b7252))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41988866-2026-07-15-2e415e8b7252`](#source-pubmed-observation-pmid-41988866-2026-07-15-2e415e8b7252))

### Sources

<a id="source-pubmed-observation-pmid-41988866-2026-07-15-2e415e8b7252"></a>
- **PubMed record PMID 41988866 · retained source version 1:2026-07-15:current:2e415e8b7252c3de88fde55e6d407857f7e2b8211d846bb876051f45530157d2** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41988866/) (`pubmed-observation-pmid-41988866-2026-07-15-2e415e8b7252`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41988866." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-41988866-dulaglutide-v1 SHA-256: bcff13c7988589766775d5c5f018f44735f1253232044b19107134e8b97e9a32.

---

<a id="pubmed-pmid-42083939-dulaglutide-v1"></a>

## PubMed record PMID 42083939

> PeptideScanner retained PubMed bibliographic metadata for PMID 42083939 at 2026-07-30T16:20:43.803Z. PubMed recorded a metadata revision date of 2026-05-05 and an Entrez history date of 2026-05-05. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42083939-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-05-05
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42083939-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-42083939-dulaglutide-v1
- Content SHA-256: `8f9a2ae30b77467efd037590e48a8fe7605e70c46ad0524a485394e42c3e975f`

### Claims and source pins

#### Headline

PubMed record PMID 42083939 ([`pubmed-observation-pmid-42083939-2026-05-05-f4cbf8622524`](#source-pubmed-observation-pmid-42083939-2026-05-05-f4cbf8622524))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42083939 at 2026-07-30T16:20:43.803Z. PubMed recorded a metadata revision date of 2026-05-05 and an Entrez history date of 2026-05-05. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42083939-2026-05-05-f4cbf8622524`](#source-pubmed-observation-pmid-42083939-2026-05-05-f4cbf8622524))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42083939 at 2026-07-30T16:20:43.803Z. PubMed recorded a metadata revision date of 2026-05-05 and an Entrez history date of 2026-05-05. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42083939-2026-05-05-f4cbf8622524`](#source-pubmed-observation-pmid-42083939-2026-05-05-f4cbf8622524))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42083939-2026-05-05-f4cbf8622524`](#source-pubmed-observation-pmid-42083939-2026-05-05-f4cbf8622524))

### Sources

<a id="source-pubmed-observation-pmid-42083939-2026-05-05-f4cbf8622524"></a>
- **PubMed record PMID 42083939 · retained source version 1:2026-05-05:current:f4cbf86225245f1796aae2564a739e9d2bd9d14faa56502b75815cd2dba59a34** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42083939/) (`pubmed-observation-pmid-42083939-2026-05-05-f4cbf8622524`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42083939." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-42083939-dulaglutide-v1 SHA-256: 8f9a2ae30b77467efd037590e48a8fe7605e70c46ad0524a485394e42c3e975f.

---

<a id="pubmed-pmid-42127399-dulaglutide-v1"></a>

## PubMed record PMID 42127399

> PeptideScanner retained PubMed bibliographic metadata for PMID 42127399 at 2026-07-30T16:20:45.678Z. PubMed recorded a metadata revision date of 2026-05-28 and an Entrez history date of 2026-05-13. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42127399-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-05-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42127399-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-42127399-dulaglutide-v1
- Content SHA-256: `851cb85861bc636a10fafc64f77eb457140f2605c40d05ac07c17aaff0b29f94`

### Claims and source pins

#### Headline

PubMed record PMID 42127399 ([`pubmed-observation-pmid-42127399-2026-05-28-a2a8d595c5af`](#source-pubmed-observation-pmid-42127399-2026-05-28-a2a8d595c5af))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42127399 at 2026-07-30T16:20:45.678Z. PubMed recorded a metadata revision date of 2026-05-28 and an Entrez history date of 2026-05-13. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42127399-2026-05-28-a2a8d595c5af`](#source-pubmed-observation-pmid-42127399-2026-05-28-a2a8d595c5af))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42127399 at 2026-07-30T16:20:45.678Z. PubMed recorded a metadata revision date of 2026-05-28 and an Entrez history date of 2026-05-13. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42127399-2026-05-28-a2a8d595c5af`](#source-pubmed-observation-pmid-42127399-2026-05-28-a2a8d595c5af))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42127399-2026-05-28-a2a8d595c5af`](#source-pubmed-observation-pmid-42127399-2026-05-28-a2a8d595c5af))

### Sources

<a id="source-pubmed-observation-pmid-42127399-2026-05-28-a2a8d595c5af"></a>
- **PubMed record PMID 42127399 · retained source version 1:2026-05-28:current:a2a8d595c5af2f3eda8309363ce8b6a2df2690077dd18c2b6384a683af5a1157** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42127399/) (`pubmed-observation-pmid-42127399-2026-05-28-a2a8d595c5af`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42127399." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-42127399-dulaglutide-v1 SHA-256: 851cb85861bc636a10fafc64f77eb457140f2605c40d05ac07c17aaff0b29f94.

---

<a id="pubmed-pmid-42239562-dulaglutide-v1"></a>

## PubMed record PMID 42239562

> PeptideScanner retained PubMed bibliographic metadata for PMID 42239562 at 2026-07-30T16:14:18.074Z. PubMed recorded a metadata revision date of 2026-06-12 and an Entrez history date of 2026-06-04. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42239562-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-12
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42239562-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-42239562-dulaglutide-v1
- Content SHA-256: `c4f0cdd6d14f0a776d0a5b51757c8d91eaa7de4a7b2bf3cbf9093d6f589398a9`

### Claims and source pins

#### Headline

PubMed record PMID 42239562 ([`pubmed-observation-pmid-42239562-2026-06-12-57fc4d4f2ebc`](#source-pubmed-observation-pmid-42239562-2026-06-12-57fc4d4f2ebc))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42239562 at 2026-07-30T16:14:18.074Z. PubMed recorded a metadata revision date of 2026-06-12 and an Entrez history date of 2026-06-04. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42239562-2026-06-12-57fc4d4f2ebc`](#source-pubmed-observation-pmid-42239562-2026-06-12-57fc4d4f2ebc))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42239562 at 2026-07-30T16:14:18.074Z. PubMed recorded a metadata revision date of 2026-06-12 and an Entrez history date of 2026-06-04. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42239562-2026-06-12-57fc4d4f2ebc`](#source-pubmed-observation-pmid-42239562-2026-06-12-57fc4d4f2ebc))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42239562-2026-06-12-57fc4d4f2ebc`](#source-pubmed-observation-pmid-42239562-2026-06-12-57fc4d4f2ebc))

### Sources

<a id="source-pubmed-observation-pmid-42239562-2026-06-12-57fc4d4f2ebc"></a>
- **PubMed record PMID 42239562 · retained source version 1:2026-06-12:current:57fc4d4f2ebcde547e4dd981fe55460d04af9bb5000599d8add8f6269778f105** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42239562/) (`pubmed-observation-pmid-42239562-2026-06-12-57fc4d4f2ebc`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42239562." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/dulaglutide.json#pubmed-pmid-42239562-dulaglutide-v1 SHA-256: c4f0cdd6d14f0a776d0a5b51757c8d91eaa7de4a7b2bf3cbf9093d6f589398a9.

